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ABSTRACT 
Ageing is associated with morphologic and functional changes in the brain, and 
is a major risk factor for cerebral vascular disease and dementia. Exercise is 
well known to promote cardiovascular health and reduce the age-related 
cognitive decline, but the mechanisms underlying this protective effect are not 
fully understood. Cardiovascular diseases, such as atrial fibrillation (AF), can 
exacerbate the risk of brain disease. This thesis aimed to assess the influence 
of ageing, exercise and AF on the cerebral blood flow and its regulation. It was 
observed that a difference of ≈55% in daily physical activity levels in a cohort of 
healthy old individuals did not influence internal carotid and vertebral artery 
blood flow. However, a high cardiorespiratory fitness was associated with 
increased bilateral internal carotid artery blood flow in young and old individuals 
when compared to their sedentary counterparts, but the influence on cerebral 
vasodilatory reserve is still unclear. AF patients had lower cerebral vasodilatory 
reserve, but preserved dynamic cerebral autoregulation, when compared to 
healthy controls. Future research is needed to elucidate whether cerebral 
haemodynamics is modified by exercise training in AF patients. 
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CHAPTER 1: INTRODUCTION 
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The maintenance of a steady cerebral blood flow is of paramount importance for 
optimal function of the brain. Even a few seconds to minutes of ischaemia can 
cause significant damage to the brain, either directly or via a secondary 
mechanism (such as falls and trauma), due to the necessity of maintaining 
homeostasis and very limited energy reserves (Madsen et al., 1998). To prevent 
hypo- or hyperperfusion, the cerebral circulation responds to changes in brain 
metabolism, arterial blood pressure, partial pressures of arterial oxygen (PaO2) 
and carbon dioxide (PaCO2) and a complex network of nerve fibres that control 
the inflow of blood to the encephalic structures (Lassen, 1959; Fox & Raichle, 
1986). 
Ageing is associated with a reduction in cerebral blood flow, as well as aspects 
of cognition such as signal processing speed, even in healthy individuals 
(Leenders et al., 1990; Burgmans et al., 2011). Furthermore, old age is one of 
the main risk factors for heart and neurodegenerative diseases, both of which 
can affect the brain (Sacco et al., 1997; Lindsay et al., 2002). Exercise has 
been proposed as a means of enhancing quality of life and reducing morbidity 
and mortality in a myriad of diseases (e.g., hypertension, dementia, diabetes), 
and a high cardiorespiratory fitness in old individuals is reported by some to 
improve cerebral vascular function and cognition (Bailey et al., 2013b; Barnes et 
al., 2013). However, little is known about the effects of physical activity and 
exercise on the cerebral blood flow and the mechanisms of its regulation in 
health and disease in ageing individuals. 
Atrial fibrillation (AF) is a heart disease strongly associated with age that 
substantially increases the risk of cerebrovascular disease and dementia (Wolf 
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et al., 1991). Even with proper optimal anticoagulant therapy, people with AF 
have an increased risk of stroke and the mechanisms of this increased risk are 
not fully understood. 
This thesis aims to assess the influence of ageing, habitual physical activity, 
cardiorespiratory fitness and AF on the cerebral blood flow and its regulation. A 
literature review (Chapter 2) will lay the foundation and identify the gaps in 
knowledge that will be addressed along the thesis, while Chapter 3 will present 
the methodology used and assess its reliability. The experimental chapters aim 
to assess the influence of healthy ageing, physical activity, cardiorespiratory 
fitness and disease on cerebral blood flow, its regulation and cognition. Chapter 
4 will determine the influence of daily physical activity on the cerebral blood flow 
and cognition in a cohort of healthy elderly individuals. Chapter 5 will extend this 
work by comparing not only cerebral blood flow but also cerebral vascular 
reactivity to CO2 in young aerobically trained and untrained and old aerobically 
trained and untrained individuals. Chapter 6 will investigate the impact of AF on 
the cerebral blood flow and its regulation, as well as cognition. The findings of 
this thesis will be summarised and integrated in Chapter 7, along with the 
provision of a perspective on the broader implications of these findings from this 
thesis and possible directions for future studies. 
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CHAPTER 2: LITERATURE REVIEW 
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This literature review will provide basic information about brain structure, 
present the methods commonly used for the assessment of cerebral blood flow, 
and outline the current understanding of the key mechanisms implicated in the 
regulation of cerebral blood flow. In addition, the effects of age, acute exercise, 
cardiorespiratory fitness and heart disease on the regulation of cerebral blood 
flow will be evaluated, with an emphasis on the limits of present understanding 
highlighted with reference to the experimental chapters contained within this 
thesis. Parts of this work have been published in The Journal of Physiology 
(Braz & Fisher, 2015). 
  
6 
 
2.1. Overview of the cerebral anatomy and circulation 
The brain is the central signal-processing unit in humans, encased by the 
cranium and considered to be the most complex organ in the body. It is 
composed by a myriad of cell types, including but not limited to neurons, 
astrocytes, oligodendrocytes, microglia, vascular and precursor cells (Darmanis 
et al., 2015). The cerebral cortex, formed mainly by the cell bodies of neurons 
and glial cells can be divided in lobes according to its topography as shown in 
Figure 2.1. These regions may be divided in sensory, motor and association 
areas which occupy specific gyri and sulci, and each area have zones related to 
a specific task. 
 
The main inflow of blood to the brain comes from two pairs of extracranial 
arteries: the internal carotid arteries (ICA) anteriorly accounting for ~72% of the 
global cerebral blood flow and the vertebral arteries (VA) posteriorly accounting 
for ~28% of the cerebral blood flow (Zarrinkoob et al., 2015). The ICA arises 
Figure 2.1. Principal fissures and lobes of the 
cerebrum viewed laterally 
From: Henry Gray (1918) Anatomy of the Human 
Body 
Licensed under Public Domain via Wikimedia 
Commons 
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bilaterally from the common carotid artery as it bifurcates to form the ICA and 
the external carotid artery approximately at the level of the fourth cervical 
vertebra. It then enters the skull through the carotid canal located in the 
temporal bone and, after providing several small branches, penetrates the Dura 
mater when exiting the cavernous sinus. In the subarachnoid space, the ICA 
provides branches to the orbit (ophthalmic artery), pituitary gland 
(meningohypophyseal and superior hypophyseal arteries) and posterior 
cerebral circulation (posterior communicating artery), before dividing into its 
terminal branches: the middle cerebral artery (MCA) and the anterior cerebral 
artery. 
The VA arises bilaterally from the subclavian arteries, proceeding cephalically 
through the transverse foramen of each cervical vertebra from C6 to C1, when 
they circle C1 and enter the cranium through the foramen magnum. Both VAs 
combine at the brainstem level to form the basilar artery, which provides several 
branches to provide blood to the brainstem via the complex vertebrobasilar 
system. The basilar artery provides branches to the cerebellum and proceeds to 
divide into the terminal branches of the posterior cerebral arteries. The posterior 
cerebral arteries receive branches from the ICA and the series of arterial 
anastomoses at the base of the brain connecting the anterior and posterior 
circulations called the circle of Willis (Figure 2.2). 
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The anterior cerebral arteries supply blood for the medial portion of the frontal 
and parietal lobes including the leg motor and sensory cortex, the anterior 
portions of most midline structures such as corpus callosum, basal ganglia and 
internal capsule. The MCAs are responsible for the irrigation of most of the 
Figure 2.2. Arteries of the brain, seen caudally 
From: "Sobo 1909 3 548" by Dr. Johannes Sobotta - Atlas and Text-book of Human 
Anatomy Volume III Vascular System, Lymphatic system, Nervous system and Sense 
Organs. Licensed under Public Domain via Wikimedia Commons 
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brain, including the frontal, temporal and parietal lobes (except from areas 
supplied by the anterior and posterior cerebral arteries), insula and deep 
structures. The posterior cerebral arteries deliver the blood to the occipital lobe, 
inferior areas of the temporal lobe and some deep structures such as the 
thalamus and cerebral peduncle. 
The cerebral arteries (i.e. MCA) provide smaller branches penetrating the 
cerebral tissue until themselves end up penetrating the brain (Cipolla, 2009). At 
the surface of the brain, the pial vessels are surrounded by the leptomeninges 
and cerebrospinal fluid until they penetrate into the brain, where they continue 
into the Virchow-Robin space. With increasing depth, the arteriolar pia-mater 
sheath gives way to the formation of the parenchymal arterioles, capillaries and 
the neurovascular units, which are comprised of the interface between the 
parenchymal arterioles and capillaries with neurons and glial cells such as the 
astrocyte end-feet (Rennels & Nelson, 1975). The neurovascular unit is where 
the glia and neurons receive nutrients and dispose of products of cerebral 
metabolism. 
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2.2. Methods for the assessment of cerebral blood flow 
The ability to measure cerebral blood flow and understand how it is regulated 
has long attracted scientists. Records from the eighteenth century show the use 
of invasive techniques to understand the cerebral circulation. Albrecht von 
Haller observed exposed pia mater to assess the cerebral volume variation and 
cerebral movement inside the skull (Haller, 1757). In the nineteenth century new 
methods were proposed including the measurement of cerebral venous outflow, 
the measurement of pressures within the systemic and cerebral circulations, 
and plethysmography of the brain in animals and people with cranial defects, as 
will be described below (Mosso, 1881; Roy & Sherrington, 1890). Other 
methods developed in the early twentieth century used local changes in tissue 
temperature, arterial-venous differences for oxygen and metabolites, and 
bubble flowmetry, which was the first technique used to quantitatively measure 
blood flow to the brain in monkeys (Dumke & Schmidt, 1943). Although the 
latter was technically challenging and needed extensive surgery and monitoring, 
meaning that it was unsuitable to be performed in humans. 
The first direct measures of cerebral blood flow in non-anesthetized humans 
were made by Kety and Schmidt (1945; 1948b) using the nitrous oxide 
inhalation technique. This technique is non-invasive, using inhalation of an inert 
gas (nitrous oxide in this case) and it is based on the fact that the rate of the 
uptake of the inert gas depends on the blood flow to that organ. Although it was 
responsible for a great contribution on the generation of knowledge on cerebral 
blood flow and its regulation, some limitations of the technique stimulated its 
improvement and the development of more sophisticated means of assessing 
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the brain circulation. In order to address the limitation of only having the global 
cerebral blood flow with the nitrous oxide inhalation technique, several 
modifications were described over the 1950s and 1960s using inert radioactive 
gases or venous and arterial blood tracers, ranging from [131I] 
trifluoroiodomethane in association with autoradiographic recordings to [85Kr] or 
[133Xe] with external scintillation detectors, to provide the detection of regional 
cerebral blood flow changes (Landau et al., 1955; Lassen & Ingvar, 1961; 
Hoedt-Rasmussen, 1965). Over the next decade, new techniques allowed for 
the assessment of regional cerebral blood flow as well as cerebral metabolism 
using tracers such as [18F] fluorodeoxyglucose or [15O] water associated with 
single-photon emission computed tomography or positron emission tomography 
(Phelps et al., 1979; Reivich et al., 1979; Raichle, 1981).  
The transcranial Doppler technique was introduced in the early 1980s (Aaslid et 
al., 1982), and it was non-invasive with a high temporal resolution in measuring 
beat-by-beat blood velocity at the cerebral arteries. This technique rapidly 
became an important tool to assess cerebral perfusion in situations where bulky 
radiation detectors were a problem, such as in many exercise settings 
(Jorgensen et al., 1992) as well as enabling the continuous monitoring of 
cerebral blood flow during surgical procedures (Spencer et al., 1990). Although 
the transcranial Doppler showed clear advantages over the known techniques 
in several situations, the main limitation of this technique is that it cannot 
measure the diameter of the insonated artery. In order to extrapolate that the 
changes in velocity are proportional to changes in blood flow, it is assumed that 
the arterial diameter is unchanged, which may not be true in some situations 
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(Wilson et al., 2011). This led to the establishment of duplex Doppler 
ultrasonography of the extracranial vessels as an equally powerful alternative of 
non-invasive measurement of cerebral blood flow for bedside or even exercise 
settings (Hellstrom et al., 1996). In contrast, new techniques were developed in 
order to achieve great spatial resolution, culminating with the development of 
blood oxygenation level-dependent contrast and arterial spin labelling used with 
magnetic resonance imaging (Ogawa et al., 1990; Williams et al., 1992), as well 
as using exogenous contrast agents to facilitate the measurement of cerebral 
blood flow (Villringer et al., 1988). The combination of these techniques, each 
with its own strengths and limitations, provided the tools to greatly improve the 
understanding of the cerebral circulation and metabolism, and how the cerebral 
microenvironment and systemic factors can influence cerebral blood flow. 
These are discussed in more detail below. 
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2.3. Cerebral metabolism 
The mass of the brain only accounts for ≈2% of total body mass, but remarkably 
the brain receives ≈15% of cardiac output during rest and the cerebral 
metabolic rate for oxygen (CMRO2) is ≈25% (≈60 mL/min) of whole-body resting 
oxygen consumption (Kety & Schmidt, 1946; Lassen, 1959). Although there is a 
small contribution from anaerobic glycolysis (≈10%), the oxidation of glucose is 
the principal mechanism by which the energy demand of the brain is met during 
resting wakefulness. As such, the molar ratio between the cerebral consumption 
of oxygen and glucose (O2-glucose index: OGI) during rest is slightly lower than 
6:1 (≈5.7) (Siesjö, 1978). However, lactate supplementation during euglycemia 
promotes a reduction in glucose utilization and may be a source of energy to 
cerebral tissue while sparing glucose, although the impact of this energy source 
during rest is still unclear (Smith et al., 2003). 
A decrease in cerebral oxygen content is associated with a reduced cerebral 
metabolism and presyncopal symptoms that may lead to syncope if not reverted 
promptly (Madsen et al., 1998). Hypoxia decreases neuronal excitatory capacity 
at first by causing neuron membrane hyperpolarisation followed by 
depolarisation that becomes permanent after a few minutes, as well as 
increasing synthesis and release of inhibitor neurotransmitters and 
neuromodulators such as γ-aminobutyric acid, adenosine, lactate and 
endogenous opioids (Neubauer et al., 1990). As the period of oxygen 
deprivation becomes longer, there is a higher proportion of neuro-glial damage, 
cell death and possibly long-term functional impairment. Not only lower oxygen 
supply can cause neuronal damage, but glucose itself also plays an important 
14 
 
role. Neurons lack storage of energy substrates and rely on the constant supply 
of glucose from the blood. Although the amount of glycogen stored primarily in 
astrocytes might be higher than of free glucose, under normal circumstances 
the glycogen utilization is slow (Oz et al., 2007). Stepped acute reductions in 
blood glucose with insulin infusion also lead to impaired brain metabolism with 
reduced glucose uptake and cognitive function (Boyle et al., 1994), and 
extremely low levels of blood glucose (e.g. lower than 1.36 mM) cause coma, 
an isoelectric electroencephalogram and, after a few minutes, neuronal death 
(Auer, 2004). On the other hand, cerebral hypermetabolism leads to lactate 
accumulation and adenosine triphosphate depletion, causing neuronal necrosis 
(Wasterlain et al., 1993) and may be associated with glutamate excitotoxicity, 
seizures and cerebral damage (Alkonyi et al., 2011). In order to maintain a 
steady blood flow supply and keep the delivery of oxygen, glucose and other 
nutrients relatively constant, and to allow adequate washout of substances such 
as CO2 and metabolic products, the brain has several mechanisms to control its 
vascular resistance and blood flow. These are described in detail below. 
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2.4. Cerebral blood flow regulation – from phenomena to 
mechanisms 
Acute reductions in cerebral perfusion, such as those that can occur during 
head-up tilt and cause a decrease in cerebral activity within a few seconds, 
characterized by light-headedness, blurred vision or a complete syncope, 
parallel to the change in perfusion (Njemanze, 1992). In contrast, cerebral 
hyperperfusion syndrome is associated with headache, vomiting, confusion, 
orbital alterations, seizures and even intracranial haemorrhage, which may 
occur in situations such as hyperperfusion after carotid endarterectomy (van 
Mook et al., 2005). The main mechanisms of cerebral blood flow regulation are 
activated by changes in cerebral metabolism, arterial blood pressure, PaCO2 
and PaO2, neural mechanisms, metabolites and cardiac output. All these 
mechanisms are tightly connected to keep the cerebral blood flow in a relatively 
constant level, which ranges around 50-60 ml·min-1·100g-1 (Leenders et al., 
1990). 
2.4.1. Neuro-glial-vascular coupling and cerebral metabolism 
More than a century ago, it was shown that cerebral blood flow would increase 
in response to peripheral nerve stimulation in dogs as measured with changes 
in cerebral volume (Roy & Sherrington, 1890) and even in humans as assessed 
using brain plethysmography in people with cranial defects (Mosso, 1881). In 
fact, after visual stimulation, an increase in blood flow at the occipital lobe was 
detectable by a localized bruit in a patient with angioma arteriale racemosum of 
the left occipital visual cortex (Fulton, 1928). This regional increase in blood flow 
was later observed with modern methods of cerebral perfusion assessment 
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such as positron emission tomography using [15O] H2O as a tracer (Fox & 
Raichle, 1984). It was proposed that the increase in regional cerebral blood flow 
was caused by the increase in cerebral activity. The phenomenon whereby an 
increase in neuronal energy expenditure is associated with an increase in 
regional blood flow is commonly known as neurovascular coupling (Attwell et 
al., 2010). Although it was originally described that the neuronal consumption of 
oxygen and glucose, and increase in metabolic by-products such as CO2, would 
eventually lead to the increase in perfusion in a negative feedback manner 
(Attwell & Laughlin, 2001), current evidence suggests that there is a 
feedforward mechanism in which the neurons and astrocytes regulate the local 
blood flow and that may even be actively modulated by pericytes and microglia 
(Filosa et al., 2015). In fact, synaptic glutamatergic stimulation can promote 
nitric oxide (NO) synthesis in the neurons which is released and diffuses to the 
vascular smooth muscle cells causing dilatation (Busija et al., 2007). In addition 
to NO, energy utilization is characterized by the metabolism of adenosine 
triphosphate into adenosine, which can bind to its A2A receptors and also cause 
cerebral vessel dilatation (Ko et al., 1990). Along with a direct effect on the 
blood vessels, neuronal activation also causes an increase in Ca2+ in 
neighbouring astrocytes, producing arachidonic acid and vasoactive metabolites 
such as prostaglandins, especially prostaglandin E2 (in neurons as well as 
astrocytes), and epoxyeicosatrienoic acids, which cause dilatation of the 
cerebral arterioles (Zonta et al., 2003). Synaptic glutamatergic stimulation also 
increases astrocytic intracellular Ca2+ in a similar rate that of neurons and 
through the arachidonic acid cascade and possibly through K+ release and 
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glutamate uptake mechanisms (Attwell et al., 2010). Ideally located with end-
feet around blood vessels, astrocytes are proposed to be the main drivers of 
cerebral vessel dilatation, being modulated primarily by neurons and also 
possibly by microglia and vascular cells (Filosa et al., 2015). Oxygen also 
influences the functional hyperaemia as a decrease in oxygenation will alter the 
production of vasoactive messengers such as NO and interfere with cerebral 
metabolism, causing an increase in adenosine due to adenosine triphosphate 
substrate utilization and lactate which will, in turn, reduce the clearance of 
prostaglandins resulting in potentiation of dilatation (Ido et al., 2001; Gordon et 
al., 2008). 
2.4.2. Arterial blood pressure 
The brain possesses the capacity to regulate its own supply of blood flow by 
changing the luminal diameter of the cerebral arteriolar beds. This phenomenon 
was first observed in cats with open cranial windows by Mogens Fog while 
studying the relationship between the arterial blood pressure and pial vascular 
tone that was independent of neurogenic stimulus (Fog, 1937, 1939). Whenever 
there is a rise in blood pressure, the smooth muscle in the arterial wall 
increases its tone, and the opposite happens with a fall in blood pressure, in 
order to keep cerebral blood flow in an optimal range for the nutrition and 
protection of the brain over a wide range of physiological arterial pressures. The 
term coined to describe this process was cerebral autoregulation (Lassen, 
1959). As shown in Figure 2.3, a plateau in cerebral blood flow was originally 
described between a blood pressure range of ≈60 mmHg to ≈150 mmHg. 
However, more recently this view has been contested in favour of a slope or a 
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plateau with a very limited range over the full autoregulatory range, (Heistad, 
1983; Rosenblum, 1995; Tan, 2012). Within these limits, there is a myogenic 
response from the cerebral arteries that counteract the increased pressure as 
demonstrated in isolated bovine cerebral arteries over a wide range of 
pressures with and without functioning smooth muscle (Vinall & Simeone, 
1981). When the smooth muscle was eliminated, the arteries behaved as 
passive conduit arteries increasing the diameter with increases in intraluminal 
pressure, while the diameter remained constant in the intact isolated arteries 
until pressures above 150 mmHg caused the arteries dilatation, often with 
discontinuous regions of smooth muscle contraction (“bead-string” or “sausage” 
patterns). While it may not account directly for cerebral blood flow regulation, 
this myogenic mechanism may protect the brain from the deleterious effects of 
increased blood pressure on the delicate vascular bed (Smeda, 1992). 
 
Figure 2.3. Limits of the cerebral autoregulation: historical view and current understanding. 
Schematic representation of cerebral blood flow over a range of blood pressure levels. The 
red curve shows the historical view of cerebral autoregulation, with a plateau of the 
cerebral blood flow ranging from 60 mmHg to 150 mmHg arterial blood pressure, while the 
blue curve shows a modern view of a varying but relatively constant cerebral blood flow in 
the autoregulatory range, with a much more limited range plateau observed. 
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Several cellular mechanisms may contribute to the phenomenon of cerebral 
autoregulation. The vascular smooth muscle cells have in their membranes 
stretch-activated cation channels that increase the membrane permeability to 
Ca2+ ions with an increase in luminal pressure, promoting vessel constriction 
(Davis et al., 1992). Several other ion channels may be directly implicated in the 
mechanism of vascular smooth muscle control of arteriolar tone (Jackson, 
2000), but their influence on the human cerebral vasculature remains to be 
proven. Other mechanisms that may influence cerebral autoregulation are 
autonomic innervation (Hamner et al., 2010; Hamner et al., 2012) and NO 
(White et al., 2000; Zhang et al., 2004), although these are subject of debate 
and their impact on cerebral autoregulation remains unresolved. 
An impairment in cerebral autoregulation is, by itself, a risk factor for the 
development of brain disease and poor outcome in several clinical conditions 
and surgical procedures such as cardiopulmonary bypass (Ono et al., 2014; 
Otite et al., 2014). Impaired cerebral autoregulation may be present, contribute 
to and potentiate the mechanism of diseases that affect the brain such as 
Alzheimer’s (Di Marco et al., 2015), ischaemic stroke (Aries et al., 2010), type 2 
diabetes mellitus (Vianna et al., 2015) and hypertension (Zhang et al., 2007). In 
fact, pharmacological treatment of hypertension or diabetes ketoacidosis 
significantly improves cerebral autoregulation in these patient groups, showing 
the importance of maintaining a good control of the underlying diseases that 
may prevent brain damage (Zhang et al., 2007; Ma et al., 2014). 
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2.4.3. Arterial blood gases 
The PaCO2 and PaO2 are strong mediators of blood flow responses in the 
cerebral circulation. In an evolutionary context these phenomena were 
hypothesised to be responsible for “washing out” excessive CO2 and hydrogen 
ions as well as increasing oxygen delivery when cerebral perfusion is 
insufficient, although this remains to be proven. The PaCO2 has been 
implicated in cerebral blood flow regulation in humans for over 80 years, even 
before the quantitative cerebral blood flow assessment techniques emerged 
(Gibbs et al., 1935). Over a decade later, there was the first direct evidence that 
increases in PaCO2 promoted a profound increase in cerebral perfusion that 
was associated with a reduction in cerebral vascular resistance (Kety & 
Schmidt, 1948a), whereas hyperventilation, and consequent hypocapnia, 
increased the cerebral vascular resistance and reduced cerebral perfusion  
(Wasserman & Patterson, 1961). This phenomenon was hypothesised to take 
place only at the smaller cerebral arteries, such as the vessels of the pia (Wolff 
et al., 1930) and cerebral surface, with dilatation of the distal middle and 
anterior cerebral arteries of nearly 29% in response to hypercapnia in contrast 
to the 4% increase in diameter of the internal carotid and vertebral arteries 
(Giller et al., 1993). However, recent evidence shows that even the large 
conduit arteries in the neck can also respond to CO2 with changes in diameter 
of ≈25% over stepped changes in PaCO2 from ≈15 mmHg to ≈65 mmHg (Willie 
et al., 2012). Furthermore, a lower blood flow reactivity to inhalation of 3% and 
6% CO2 was observed in the posterior circulation of the brain, with the vertebral 
artery responding ≈30% less than the internal carotid artery and it was 
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proposed that this lower reactivity to CO2 would be advantageous to the 
protection of the brain regions controlling vital functions (Sato et al., 2012b), 
although this has not been a universal finding (Willie et al., 2012). 
Although the exact mechanisms by which CO2 modifies cerebral vascular 
smooth muscle tonus are still unclear, it is currently accepted that CO2 itself 
lacks direct vascular action and exerts its vascular effects through changes in 
tissue pH and vasoactive substances (Figure 2.4). It has been shown that, with 
direct measurement of cerebral arterial diameters in cats through a cranial 
window, synthetic cerebral spinal fluid with high or low CO2 levels did not 
modulate arterial diameter when pH was maintained constant, while cerebral 
spinal fluid alkalosis or acidosis would cause arterial constriction and dilatation 
respectively regardless of maintained or altered CO2 levels (Kontos et al., 
1977). The cerebral tissue changes in pH that are followed by an increase or 
decrease in CO2 levels may cause potassium channels in the endothelium and 
vascular smooth muscle to be activated or closed (causing hyperpolarization or 
reducing the depolarization threshold, respectively), therefore modulating 
vascular tonus and resistance (Faraci & Sobey, 1996; Kinoshita & Katusic, 
1997). Increased PaCO2 may also contribute to cerebral vasodilatation via a 
NO-mediated mechanism, and NO molecular pathways are present in neurons, 
endothelium, and glial cells (Faraci & Brian, 1994). Pharmacological blockade of 
the NO pathways impairs cerebral vascular reactivity to CO2 and also interferes 
with the pH-mediated vascular responses (Wang et al., 1992). However, even 
after blockade of NO pathways (such as blocking NO synthase enzyme), severe 
hypercapnia (PaCO2 >100 mmHg) still promoted an increase in cerebral blood 
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flow and this suggests that cerebral perfusion response to hypercapnia has NO-
dependent and independent pathways (Iadecola & Zhang, 1994). Evidence 
shows that patients with diabetes and arterial hypertension, conditions in which 
endothelial function is impaired, have reduced cerebral vascular reactivity to 
CO2 when compared to healthy controls, while the administration of a NO donor 
(sodium nitroprusside) abolished this difference (Lavi et al., 2006). Hypocapnic 
tests, with or without NO blockade, show that this mechanism is not implicated 
in cerebral vasoconstriction (Wang et al., 1992). Furthermore, cerebral 
endothelial NO production may also be stimulated mechanically, where the 
shear stress causes an up-regulation of the endothelial NO synthase system 
(Schmidt et al., 2013). 
 
The cerebral vascular reactivity to CO2 can be impaired in conditions such as 
traumatic brain injury, Alzheimer’s disease and even hypertension (Ficzere et 
Figure 2.4. Putative mechanisms of cerebral vessel dilatation during hypercapnia 
Increased CO2 pressure leads to a lower extracellular pH, which, in turn, stimulates production 
of nitric oxide (NO) in the endothelium, astrocytes and neurons and, via an unknown 
mechanism, acts directly reducing intracellular Ca
2+
 concentration promoting smooth muscle 
relaxation. Nitric oxide acts directly in K
+
 channels as well as increasing cyclic guanosine 
monophosphate (cGMP) which will reduce Ca
2+
. 
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al., 1997; Gao et al., 2013; Len et al., 2013), and it may be an independent risk 
factor for cerebral vascular disease (Molina et al., 1999; Reinhard et al., 2014). 
Furthermore, manipulation of CO2 has long been used to control cerebral 
perfusion in a myriad of clinical situations such as traumatic brain injury, 
cerebral ischaemia and during surgical procedures (Brian, 1998). Although 
therapeutic hypocapnia has been used clinically for treating patients with acute 
traumatic brain injury, it has been shown that hyperventilation can cause 
marked cerebral vasoconstriction and increase the incidence of cerebral 
ischaemia (Muizelaar et al., 1991). 
Arterial oxygen can also influence cerebral perfusion, both directly and 
indirectly. Cerebral blood flow tends to remain constant with mild to moderate 
reductions in PaO2, reflecting a balance of the hypoxic-mediated cerebral 
vessels dilatation and hypocapnic-mediated vessel constriction, the latter of 
which is a result of a hyperpnoeic ventilatory response driven by the carotid 
body chemoreceptors (Teppema & Dahan, 2010). However, when PaO2 is 
reduced to lower than ≈50 mmHg, there is a progressive increase in cerebral 
perfusion associated with a reduction in cerebral vascular resistance in dogs 
(Kogure et al., 1970). In humans, cerebral perfusion remains constant until a 
decrease in peripheral oxygen saturation to 90%, beyond this a progressive 
increase in perfusion occurs (Gupta et al., 1997). With the normal 
haemoglobin/oxygen dissociation curve, the threshold would be at ≈ 58 mmHg 
PaO2. In contrast, even moderate hyperoxia leads to cerebral vasoconstriction 
and consequent reduction in cerebral perfusion, although this effect is less 
pronounced than the hypoxic response (Bulte et al., 2007). Several 
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mechanisms have been implicated in the cerebral vascular responses to 
changes in arterial oxygen content. Adenosine is released in response to 
hypoxia and is reportedly one of the main stimulators of hypoxic-mediated 
cerebral vessel dilatation (Phillis, 1989). The blockade of adenosine receptors 
by theophylline blunts the cerebral vascular dilatation to hypoxia (Bari et al., 
1998), although the magnitude of the contribution of this mechanism is still 
controversial (Haller & Kuschinsky, 1987; Morii et al., 1987; O'Regan, 2005). 
Prostacyclin, a prostaglandin with dilatory properties, has also been implicated 
in the cerebral vascular response to hypoxia (McCalden et al., 1984). However, 
there is evidence that the relative cerebral vascular response to hypoxia is 
maintained after cyclooxygenase inhibition, and effect of prostaglandins on the 
cerebral vascular response to hypoxia requires clarification (Hoiland et al., 
2015). Hypoxia may also have a direct effect on the smooth muscles 
surrounding the cerebral arteries. Impaired oxidation of energetic molecules and 
consequent adenosine triphosphate depletion will result in a reduced contractile 
capacity by inhibition of cytosolic calcium influx and increased potassium efflux 
(Tomiyama et al., 1999; Phillis, 2004). Prolonged hypoxia will cause 
extracellular fluid acidification and potassium release, which will promote 
cerebral vascular dilatation in the same way as with the hypercapnic response. 
In contrast to hypoxia, isocapnic hyperoxia at a target partial pressure of end-
tidal oxygen of 500 mmHg, mean blood flow at the carotid arteries and cerebral 
blood volume measured by magnetic resonance imaging remained constant 
(Croal et al., 2015). Similarly, at 320 mmHg to 430 mmHg PaO2, the ICA and 
VA blood flow remained unchanged from baseline values as measured by 
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Doppler ultrasound (Willie et al., 2012). However, other studies have found that 
the cerebral perfusion is significantly reduced with isocapnic hyperoxia by 
increasing the inspired fraction of oxygen to 100% (Kolbitsch et al., 2002) or 
achieving PaO2 of ≈482 mmHg (Tajima et al., 2014). One possible explanation 
for this contradictory evidence is that after an initial hypoventilatory response, 
hyperoxia may cause a mild progressive hyperventilation, which can reduce the 
PaCO2 leading to cerebral vasoconstriction (Marczak & Pokorski, 2004). 
2.4.4. Autonomic nerves and intrinsic pathways in the brain 
The blood vessels at the surface of the brain are innervated with fibres from the 
superior cervical, sphenopalatine, otic and trigeminal ganglia, and 
neurotransmitters such as acetylcholine, nitric oxide, vasoactive intestinal 
peptide, norepinephrine, neuropeptide Y  and others have been implicated in 
this signalling (Hamel, 2006). Although many animal models are used to assess 
the influence of the autonomic nervous system on the cerebral blood flow 
regulation, the invasiveness of most studies prevent the translation of these 
methods for human use, and this literature review will focus on the data in 
humans. 
The sympathetic nervous system’s contribution to the control of the cerebral 
circulation is still highly debated (Strandgaard & Sigurdsson, 2008; van Lieshout 
& Secher, 2008b). Routine upper thoracic sympathectomy has been shown to 
increase arterial diameter and blood flow at the ICA in a cohort of 68 patients 
with palmar hyperhidrosis (Jeng et al., 1999) whereas bilateral stellectomy 
promoted a reduction in cerebral vascular resistance with a non-significant 
increase in cerebral blood flow (Shenkin et al., 1951). However, studies using 
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pharmacological blockade show conflicting results. Stellate ganglion blockade 
has been shown to increase cerebral perfusion both at rest measured by 
scintigraphy (Umeyama et al., 1995) and during exercise with transcranial 
Doppler (Ide et al., 2000a). In contrast to these findings, other studies showed 
the cerebral blood flow may be unaffected or even reduced after stellate 
blockade when measured by the [133Xe] technique or magnetic resonance 
imaging respectively (Ohta et al., 1990; Kang et al., 2010). Thus, if the 
sympathetic nervous system has any effect on the cerebral circulation, the 
driving factor that commands the responses may be linked to changes in 
cardiac output, as described in the next section (van Lieshout & Secher, 
2008a). The sympathetic nervous system has also been implicated as a 
modulator of cerebral autoregulation as α-adrenergic blockade with 
phentolamine was associated with an increased transfer function coherence 
between arterial blood pressure and cerebral perfusion (Hamner et al., 2010). 
This suggests that the buffering provided by the myogenic mechanism to 
changes in blood pressure is lost without the influence of the sympathetic 
nervous system. 
Parasympathetic fibres arising from the sphenopalatine, internal carotid and otic 
ganglions, and the nucleus basalis of Meynert innervate cerebral blood vessels 
(Biesold et al., 1989; Suzuki et al., 1990) and, although there is evidence that 
the parasympathetic nervous system plays an important role in modulating 
cerebral blood flow in non-human animal species (Biesold et al., 1989; Toda & 
Okamura, 1990), current evidence in humans is contradictory. Administration of 
glycopyrrolate, a cholinergic blocker that does not cross the blood-brain barrier, 
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impaired cerebral autoregulation at higher frequencies of oscillatory lower body 
negative pressure (Hamner et al., 2012) and abolished the exercise-induced 
increase in MCA Vmean using transcranial Doppler (Seifert et al., 2010). 
However, it was shown that an increase in regional cerebral blood flow of the 
motor cortex evoked by a visual or motor task was not influenced by cholinergic 
blockade with glycopyrrolate in one recent study using the arterial spin labelling 
and blood oxygen level dependent techniques (Rokamp et al., 2014). Additional 
studies are required to further investigate the influence of intrinsic and extrinsic 
autonomic fibres on the regulation of cerebral blood flow. 
2.4.5. Cardiac output 
There is mounting evidence that cardiac output regulates cerebral perfusion 
independently from changes in arterial blood pressure and PaCO2 and PaO2. In 
healthy young individuals, the application of graded lower body negative 
pressure to reduce central blood volume and cardiac output, also reduced 
cerebral perfusion even before any decrease in arterial blood pressure (Levine 
et al., 1994). During head-up tilt, a manoeuvre also used to reduce central blood 
volume, cerebral perfusion was decreased despite an increase in mean arterial 
pressure and a maintained PaCO2 (Jorgensen et al., 1993). Conversely, 
increasing central blood volume with venous infusion of a 25% albumin solution 
caused an increase in cardiac output that was coupled with an increase in 
cerebral perfusion (Ogoh et al., 2005). A similar result was observed when 15 
and 30 mL/kg of normal saline solution were infused in healthy young 
individuals, which increased cardiac output by ≈0.57 L/min (15 mL/kg) and 
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≈0.92 L/min (30 mL/kg) leading to an increase in MCA Vmean of 5 cm/s (15 
mL/min) and 6 cm/s (30 mL/min), respectively (Ogawa et al., 2007). 
The mechanisms responsible for the association between cardiac output and 
cerebral perfusion remain hypothetical. It has been proposed that small vessel 
vasoconstriction may be the mechanism underpinning a reduced cerebral 
perfusion caused by the reduced cardiac output (Levine et al., 1994). This 
would be explained by the increased pulsatility index detected, as this index is 
related to intracranial pressure and may be indicative of cerebral vascular 
resistance, although this last assumption is not always true (de Riva et al., 
2012). Most of the above studies related the change in cerebral perfusion with 
indices of cerebral vascular resistance, implying that the changes in cardiac 
output are coupled with resistance vessels tone (Levine et al., 1994; Ogoh et 
al., 2005). In fact, one study hypothesised that the cerebral responses to a 
change in cardiac output is mediated by the sympathetic innervation of the brain 
vessels (Ogoh et al., 2005). However, direct evidence for the autonomic 
regulation of the cerebral circulation in response to changes in cardiac output is 
lacking. 
Cardiac output is reduced in diseases such as heart failure and AF and this 
reduction may explain several of the brain-related symptoms often perceived by 
the patients (Petersen et al., 1989b; Fraser et al., 2015). Cerebral perfusion was 
improved in patients with heart failure after treatment with captopril (inhibitor of 
the angiotensin converting enzyme), cardiac transplantation or electrical 
therapies such as cardiac resynchronization therapy, all of which improve 
ventricular function (Meng et al., 2015). However, the contribution of changes in 
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blood pressure and direct effects of the medication on the cerebral circulation 
cannot be excluded. 
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2.5. The ageing brain: structure and function 
Ageing is a natural biological process characterized by a series of cumulative 
alterations that can be observed from the molecular to the organism level. 
There are several reasons why these alterations are thought to occur, ranging 
from DNA replication flaws, errors on protein synthesis, damage caused by 
increased oxidative stress and free radicals, disruptive binding of 
macromolecules and deleterious immune responses (Harman, 1981). After 
achieving the peak function, which can happen at any time from the early 
adolescence to adulthood, the changes that occur during the ageing process 
becomes progressively clearer and the functional limitations also become more 
apparent (Bafitis & Sargent, 1977). Public health interventions along with health 
care and education improvements over several decades, have led to an 
increase in life expectancy and global population ageing (Salomon et al., 2012). 
Age is one of the most important risk factors for brain diseases such as 
dementia and stroke (Sacco et al., 1997; Lindsay et al., 2002), but even in 
‘healthy ageing’ brain structure and function are altered (Scahill et al., 2003; 
Burgmans et al., 2011). Grey and white matter blood flow decrease by ~0.5% 
per year from early adulthood, and despite a small increase in oxygen 
extraction, the CMRO2 may also be decreased (Leenders et al., 1990). In fact, 
resting CMRO2 is reported to be reduced with ageing in some (Kety, 1956; 
Pantano et al., 1984), but not all studies (Burns & Tyrrell, 1992). Ageing also 
causes a reduction in cerebral metabolic rate for glucose (Nugent et al., 2014), 
which is estimated to decline by ~6% per decade globally with most cerebral 
regions affected, except for the occipital cortex and cerebellum (Petit-Taboue et 
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al., 1998). However, this age-related impairment in cerebral perfusion and 
metabolism may be confounded by the incidence of subclinical disease such as 
arteriosclerosis, cognitive impairment, hypertension and further changes in 
cerebral metabolism due to neuronal loss that can also be implicated in a lower 
cerebral blood flow in ageing. Advancing age is also associated with cerebral 
atrophy (particularly in frontal and temporal regions), altered neural signalling, 
and impairments in aspects of cognition (e.g., working memory and processing 
speed) (Martin et al., 1991; Jagust, 2013). 
Despite the scientific progress in understanding the cerebral circulation and its 
regulation over the last few decades, the mechanisms of structural and 
functional cerebral vascular changes seen in ageing and disease are still 
unclear. 
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2.6. Cerebral blood flow and exercise 
Physical activity comprises any bodily movement made by skeletal muscles that 
result in energy expenditure. Exercise is defined as a planned, structured 
physical activity which has a goal of maintaining or improving physical function 
such as cardiorespiratory fitness as measured by oxygen consumption 
(Caspersen et al., 1985). Physical activity and exercise have long been 
proposed as a means of improving cerebral health (Dustman et al., 1984; 
Clarkson-Smith & Hartley, 1989; Paillard et al., 2015) and exercise has also 
been used to assess cerebral vascular responses to a physiological stressor 
(Davenport et al., 2012). The prevalence of physical activity and exercise has 
been shown to decrease ≈33% over a 10-year period in men aged 65 or older 
(Bijnen et al., 1998), and promoting at least moderate levels of physical activity 
may protect this segment of the population against chronic diseases (DiPietro, 
2001). However, the effects of physical activity and exercise on the cerebral 
blood flow and its regulation in old individuals are not completely understood 
and will be presented in section 2.6.3. The following section pertaining to 
cerebral blood flow (2.6.1) and metabolism (2.6.2) during exercise, have been 
published as part of a recent Journal of Physiology review article (Braz & 
Fisher, 2015). 
2.6.1. Acute effects of exercise on the cerebral blood flow 
Studies using the Kety and Schmidt technique reported that global cerebral 
blood flow was unchanged during exercise (Scheinberg et al., 1954; Kleinerman 
& Sancetta, 1955; Lambertsen et al., 1959). However, a change in subject 
position from rest (supine) to exercise (upright), an associated change in the 
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anatomy of cerebral drainage, confounding alterations in PaCO2, and a reduced 
activation in some brain regions during exercise, may in part explain these 
observations (Secher et al., 2008).  
The administration of dissolved inert radioactive gases such as [133Xe] and 
[85Kr] via the common carotid artery and measurement of the emitted radiation 
by extracranial scintillation detectors permitted the earliest determination of 
regional cerebral blood flow responses to exercise (Hoedt-Rasmussen, 1965). 
Accordingly, Olesen (1971) observed a regional increase in perfusion of the 
cortical sensorimotor area corresponding to the hand during contractions with 
the contralateral hand. A ~10-30% increase cortical blood flow is also elicited by 
leg cycling, as determined with the [133Xe] clearance initial slope index 
(Jorgensen et al., 1992). This is paralleled by a comparable increase in MCA 
Vmean (Jorgensen et al., 1992) measured using the transcranial Doppler 
technique introduced by Aaslid and colleagues (Aaslid et al., 1982). In fact, leg 
cycling bilaterally increases Vmean in the MCA and anterior cerebral artery, 
whereas rhythmic handgrip exercise performed with the right hand principally 
increases the left MCA Vmean, and calf exercise performed with the right leg 
predominantly increases Vmean in the left anterior cerebral artery (Linkis et al., 
1995). Positron emission tomography and single-photon emission computed 
tomography have confirmed the exercise-induced regional increase in cerebral 
perfusion and activation in the sensorimotor and premotor regions, as well as 
the supplementary motor area, cerebellum and insular cortex (Williamson et al., 
1999; Hiura et al., 2014), and highlights the coupling between regional cerebral 
activation and perfusion during exercise. Along with an increase in MCA Vmean, 
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blood flow in the internal carotid and vertebral arteries increases by ~17% 
during moderate intensity leg cycling (Hellstrom et al., 1996; Sato et al., 2011). 
However, at exercise intensities above ~60% maximal oxygen uptake (VO2max) 
MCA Vmean and internal carotid artery flow plateau and then return toward 
resting levels as exercise intensity increases, whereas in contrast vertebral 
artery flow continues to increase up to 80% VO2max (Sato et al., 2011). 
2.6.2. Cerebral metabolism during exercise 
Early reports that global cerebral blood flow was unchanged during exercise, 
also suggested that cerebral metabolism was unaltered (Madsen et al., 1993), 
and in fact it was even concluded that "during vigorous physical exercise the 
brain behaved as a steady-state organ with little or no change in cerebral 
circulation or metabolism" (Zobl et al., 1965). However, cerebral activation with 
tactile stimulation increases regional cerebral blood flow and CMRO2 (Fox & 
Raichle, 1986), and the same appears be true for CMRO2 during exercise 
(Seifert et al., 2009; Smith et al., 2014) although this has not been universally 
observed (Trangmar et al., 2014). The cerebral metabolic rate for glucose and 
the OGI tend to be similar at rest and during exercise (Ide et al., 2000b), 
although OGI can be reduced by very strenuous exercise, such as prolonged 
maximal exercise in the heat (Nybo et al., 2003). Along with glucose, lactate 
also plays an important role as a substrate during exercise (Smith et al., 2003), 
particularly when arterial lactate concentration is elevated such as during high 
intensity exercise. The combined uptake of glucose and lactate relative to 
oxygen remains stable at low-to-moderate exercise intensities, but when 
exercise becomes more strenuous glucose and lactate uptake increase in 
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excess of oxygen, in an intensity dependent manner. This means that the 
‘oxygen-to-carbohydrate consumption index’ (OCI; O2/[glucose +½ lactate]) is 
reduced, and during all-out rowing the OCI can decrease to <35% of the 
baseline value (Volianitis et al., 2008). As the increase in cerebral uptake of 
lactate does not result in an accumulation of this substance in brain structures 
or in the cerebral spinal fluid, it is seemingly metabolized by the brain during 
exercise (Dalsgaard et al., 2004). 
2.6.3. Chronic effects of exercise on cerebral blood flow 
It is well known that regular exercise reduces cardiovascular risk (Mora et al., 
2007) and improves systemic arterial function via a series of mechanisms 
including NO (DeSouza et al., 2000) and arterial compliance (Ashor et al., 
2014). However, the chronic effects of regular daily physical activity or exercise 
training on the cerebral circulation are still unclear. It has been previously 
shown that a higher VO2max was associated with a higher resting MCA Vmean in 
young individuals and throughout the lifespan (Ainslie et al., 2008; Bailey et al., 
2013b), although this is not a universal finding (Zhu et al., 2013; Brugniaux et 
al., 2014). When assessed by magnetic resonance imaging, whole brain 
averaged blood flow in sedentary elderly individuals was not different when 
compared to masters athletes, although there was a significantly increased 
cerebral blood flow to brain regions such as the posterior cingulate cortex 
(Thomas et al., 2013). Furthermore, the effects of cardiorespiratory fitness on 
the cerebral vascular reactivity to CO2 (CVRCO2) are also controversial, with 
evidence showing that CVRCO2 was improved (Bailey et al., 2013b; Barnes et 
al., 2013), unchanged (Zhu et al., 2013) or even reduced (Thomas et al., 2013) 
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in trained individuals when compared to sedentary age-matched controls. 
Potential mechanisms proposed to mediate improved cerebral haemodynamics 
resulting from chronic exercise may include, brain-derived neurotrophic factor, 
insulin-like growth factor 1, or prostaglandin activation (Bailey et al., 2013b; 
Barnes et al., 2013). Neurotrophic factors such as the nerve growth factor and 
brain-derived growth factor have been shown to reduce infarct area in rats that 
exercised in a treadmill for 12 weeks (Ang et al., 2003). Furthermore, insulin-like 
growth factor 1 also plays a role by promoting angiogenesis by the stimulation 
of vascular endothelial growth factor, as well as stimulating the production of 
brain derived neurotrophic factor  (Carro et al., 2000; Lopez-Lopez et al., 2004). 
Finally, inhibition of the cyclooxygenase enzyme with indomethacine caused fit 
old adult humans to have a reduced response to inhaled CO2 in contrast to a 
control condition, suggesting that prostaglandins may be partially responsible 
for the cerebral vascular adaptations to exercise (Barnes et al., 2013). The 
effects of daily physical activity and cardiorespiratory fitness on the cerebral 
blood flow and CVRCO2 will be discussed in detail in Chapter 4 and 5. 
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2.7. Atrial fibrillation – from the heart to the brain 
AF is the most common sustained heart rhythm abnormality and has a lifetime 
incidence risk of 26% in men and women aged over 40 years old (Lloyd-Jones 
et al., 2004). The incidence and prevalence of AF is strongly correlated with 
advanced age. There are several potential mechanisms through which AF may 
influence cerebral blood flow and its regulation. These will be discussed below 
and will be further detailed in chapter 6. 
2.7.1. Definition, epidemiology and pathophysiology 
The defining characteristics of AF are the presence of an absolutely irregular 
heart rhythm and absent P waves in the electrocardiogram (ECG, Figure 2.5). 
This disease can present itself in different ways according to the duration of the 
bouts of fibrillation: paroxysmal, when the episode resolves spontaneously 
within 48h; persistent, when the abnormal heart rhythm persists for longer than 
7 days, needs cardioversion or rhythm controlling medications; and permanent, 
when the patient persists in long-standing AF even after cardioversion is 
attempted or is considered inappropriate and rhythm control is not pursued 
(Camm et al., 2010). The prevalence of AF in the general population is ≈2% in 
Europe and is steadily increasing (Zoni-Berisso et al., 2014). While the younger 
segments of the population experience very low rates of AF prevalence (0.2 to 
0.6% in people up to 49 years old), older segments of the population face much 
higher prevalence of AF (over 10% in individuals ≥80 years old). It is more 
common in men, with a ratio 1.2:1 when compared to women (Camm et al., 
2010; Zoni-Berisso et al., 2014). 
38 
 
 
Structural changes in the atria increase the arrhytmogenic potential and may 
precede the onset of AF. These changes include alterations in the extracellular 
matrix, myocytes, with endocardial and microvascular remodelling (Camm et al., 
2010). Furthermore, an increased vagal tone which prolongs the PR interval, 
added to the increased cardiac stress during vigorous physical activity have 
been proposed as mechanisms of a higher incidence of AF in endurance 
athletes, although this remains controversial (Wernhart & Halle, 2015). After its 
onset, AF causes inflammatory changes that may fulfil criteria for the diagnosis 
of myocarditis, noninflammatory cardiomyopathy and fibrosis even in patients 
with lone AF (Frustaci et al., 1997). The pulmonary veins are the source of the 
arrhythmia in the majority of patients, possibly due to shorter refractory periods 
and a different myocyte arrangement (Haissaguerre et al., 1998). The high 
ventricular rates achieved during episodes of AF may cause a ventricular 
cardiomyopathy, which in turn reduces cardiac output and is associated with 
poorer long-term outcomes (Lin et al., 2010). Even within the normal heart rate 
The P wave is observed in the sinus rhythm (lower trace, arrow) while 
the AF shows no identifiable P waves (upper trace, arrow). 
From: J. Heuser (2005) Licensed under GNU Free Documentation 
License 
Figure 2.5. Electrocardiogram of atrial fibrillation (AF, top) and normal 
sinus rhythm (bottom). 
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range, the chaotic atrial electrical activity causes a reduction in cardiac output of 
≈5-15%, with some patients presenting overt heart failure (Camm et al., 2010). 
Furthermore, the disrupted atrial systole and atrial enlargement in AF causes 
stasis, combined with increase of pro-inflammatory cytokines and a general shift 
of the coagulation cascade to a prothrombotic state results in intravascular 
activation of coagulation, which is one of the most damaging complications of 
AF (Watson et al., 2009). In addition, it has been shown that AF patients have 
systemic endothelial dysfunction as characterized by impaired flow-mediated 
dilatation, increased plasma von Willebrand factor and E-selectin (Freestone et 
al., 2008). NO is one of the most important vasoactive substances produced by 
the endothelium and it is thought to be the major endothelial factor regulating 
cerebral vascular tone (Faraci & Heistad, 1998). In fact, administration of a NO 
donor (glyceryl trinitrate) to AF patients increased flow-mediated dilatation 
responses to levels similar to that observed in a healthy control group, 
indicating a major role of the NO mechanism to arterial dilatation in AF 
(Freestone et al., 2008). The endothelial dysfunction/damage as characterized 
by increased plasma von Willebrand factor has also been shown to be a 
predictive factor for cerebrovascular events (Conway et al., 2003). However, 
little is known about how these mechanisms interact at the cerebral circulation 
and this knowledge may assist in the development of strategies to prevent 
complications of the disease. 
2.7.2. Diagnosis, treatment and potential complications 
This section is based on the NICE (2014) and European (Camm et al., 2010) 
clinical guidelines. 
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AF is usually suspected on the basis of a patient presenting with an irregular 
pulse that may or may not be accompanied by symptoms. Common symptoms 
are palpitations, dizziness, fatigue, dyspnoea, chest pain or even heart failure. 
In some cases, patients will have as first symptoms cerebral vascular 
manifestations such as a transient ischaemic attack or stroke. The diagnosis is 
made with the electrocardiographic identification of AF whether symptoms are 
present or not. In patients in whom AF is strongly suspected but is not 
confirmed by routine ECG (i.e. in patients with paroxysmal AF in sinus rhythm 
during the consultation), a longer recording period such as a 7-day Holter ECG 
may be warranted.  
The treatment options for AF include cardioversion (electric or 
pharmacological), rhythm control medication, rate control medication and 
anticoagulation, and should be individually tailored in order to reduce the 
symptoms (if any) and prevent stroke, one of the main long-term complications 
of the disease. Of note, the relative risk of stroke ranges from 2.6 to 4.5 in 
patients with AF when compared to healthy controls (Wolf et al., 1991). 
Strategies targeting stroke prevention, haemodynamic improvement and 
reduction of symptoms are the cornerstones of AF therapy. Prevention of stroke 
is achieved with the use of oral anticoagulants and haemodynamic and 
symptomatic improvement is attempted with rhythm or rate control medication. 
Treatment with anticoagulants reduces the risk of stroke in AF to a level near 
that observed in the general population (Petersen et al., 1989a). 
AF is associated with cognitive impairment and dementia (e.g. Alzheimer’s 
disease) even in patients without evidence of stroke (Ott et al., 1997). One 
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proposed mechanism for this increase in incidence of dementia is the 
occurrence of silent cerebral infarcts, as a result of small vessel damage 
causing subcortical lesions (Vermeer et al., 2003). A relative cerebral 
hypoperfusion due to the lower cardiac output or other unknown mechanism in 
AF patients has also been proposed as another mechanism that may contribute 
to the cognitive decline in this group (Alosco et al., 2015). Although resting 
steady-state cerebral perfusion assessments provide valuable information to 
understand the pathophysiology of the complications of AF, dynamic studies on 
the cerebral vascular function in humans are warranted to further knowledge on 
the status of the cerebral vasculature in response to different stressors. 
2.7.3. Cerebral blood flow in atrial fibrillation 
Cerebral blood flow is reported to be lower in chronic AF patients when 
compared to controls especially in younger age groups (Lavy et al., 1980). 
During an episode of paroxysmal AF, MCA Vmean is acutely lowered and 
increases once the arrhythmia was resolved (Totaro et al., 1993). Similarly, 
cerebral blood flow is improved after cardioversion in patients with AF when 
measured by [133Xe] (after correction for changes in partial pressure of end-tidal 
CO2 [PETCO2]), becoming similar to values obtained in healthy individuals 
(Petersen et al., 1989b). In contrast to these findings, one study did not find a 
significant difference in MCA Vmean between paroxysmal AF patients and 
controls (Porebska et al., 2007). In the same study, cardioversion was 
associated with a significantly increased MCA Vmean when compared to values 
before the procedure. In AF the ability to increase cerebral perfusion during 
exercise is diminished, along with the ability to increase cardiac output. 
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Whereas control participants had a 23% increase in MCA Vmean during intense 
cycling exercise, in AF patients it was only 9% (Ide et al., 1999). The reduction 
in cerebral perfusion in AF, secondary to a reduction in cardiac output, can 
further be complicated by other diseases such as heart failure. Patients with AF 
and heart failure (NYHA ≥ 2) had a lower MCA Vmean, and poorer memory and 
global cognition, when compared to patients with heart failure without AF 
(Alosco et al., 2015). Furthermore, although endothelial function and NO are 
known to be impaired in AF and are important modulators of cerebral 
haemodynamics, the impact of the endothelial dysfunction on the cerebral 
vasculature in this patient group remains to be elucidated. Therefore, studying 
the cerebral blood flow and its regulation in patients with AF is imperative in 
order to identify mechanisms of cerebral vascular damage and devise strategies 
for prevention and treatment of the much feared complications of this disease. 
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2.8. Aims and hypotheses of this thesis 
Understanding of how healthy ageing and disease affect the regulation of 
cerebral blood flow, and how this may be modified by physical activity, is 
incomplete. The specific questions that are to be addressed in this thesis are: 1) 
How does normal daily physical activity influence global cerebral blood flow in 
healthy older individuals? 2) Does a higher cardiorespiratory fitness elevate 
cerebral blood flow and improve CVRCO2 in healthy young and elderly 
individuals? 3) Is cerebral vascular function impaired in patients with AF? 
These questions will be addressed in the experimental chapters of this thesis, 
with the following specific aims and hypotheses: 
Chapter 4: To investigate if normal daily physical activity influences resting 
cerebral blood flow in a cohort of elderly individuals. It was hypothesised that 
people who had higher levels of daily physical activity would have higher 
cerebral blood flow when compared to people with the lowest levels of physical 
activity from the cohort. 
Chapter 5: To investigate if age and cardiorespiratory fitness influence resting 
cerebral blood flow and CVRCO2. It was hypothesised that bilateral ICA and VA 
blood flow and CVRCO2 would be greater in aerobically trained young and old 
individuals compared to their untrained counterparts. 
Chapter 6: To investigate whether AF influences resting cerebral perfusion, 
CVRCO2 and cerebral autoregulation. It was hypothesised that people with AF 
would have lower cerebral perfusion, CVRCO2 and impaired cerebral 
autoregulation when compared to healthy age-matched controls.  
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CHAPTER 3: GENERAL METHODS 
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3.1. Ethical approval and consent 
All procedures were approved by local ethical committees and conformed to the 
Declaration of Helsinki. The studies presented on chapters 4 and 6 were 
approved by the Health Research Authority (formerly National Research Ethics 
Service) of the United Kingdom, while chapter 5 had approval from the Swiss 
Federal Institute of Technology Zurich. Potential participants received an 
information sheet containing details of the research and, after having all the 
procedures explained and being given the opportunity to ask questions, written 
informed consent was obtained prior to the participation in each study. 
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3.2. Variables measured 
3.2.1. Haemodynamic and respiratory 
Resting blood pressure was assessed on the brachial artery using the 
oscillometric principle (Dinamap ProCare 200, GE Medical Systems, 
Milwaukee, WI, USA – Chapters 4 and 5; M2, Omron, Kyoto, Japan – Chapter 
6) or an automated auscultatory R-wave gating algorithm (Tango+, SunTech 
Medical, Eynsham, UK – Chapter 3). Furthermore, beat-by-beat changes in 
blood pressure were continuously recorded non-invasively using finger 
photoplethysmography (Portapres, Chapter 5; Finometer MIDI, Chapter 6; all 
made by Finapres Medical Systems, Amsterdam, the Netherlands). This 
methodology has been shown to agree with intra-arterial measurement of blood 
pressure, allowing the real-time beat-by-beat monitoring of blood pressure 
changes during dynamic manoeuvres such as tilt test (Petersen et al., 1995). 
Systolic and diastolic blood pressures were recorded, and mean arterial 
pressure (MAP) was calculated according to the formula:              
       , where SBP denotes systolic blood pressure and DBP denotes 
diastolic blood pressure. Heart rate was calculated using the R wave peaks 
from a continuously recorded lead II ECG (BioAmp, ADInstruments, Dunedin, 
New Zealand). The choice of using lead II ECG was made because the 
placement of the electrodes on the base of the right upper limb (negative) and 
left lower limb (positive) provide a superior-inferior plane of reference of the 
heart, allowing a best possible visualization of the upward P waves and a well-
defined R wave peak in people with normal cardiac axis (Meek & Morris, 2002). 
Respiratory variables were recorded continuously through a face mask and two-
47 
 
way valve (Hans Rudolph, Kansas City, KS, USA – Chapters 5 and 6) or, when 
only PETCO2 was feasible, through a nasal cannula (PROBreathe nasal 
cannula, PROACT Medical, Corby, UK – Chapter 4). Respiratory flow was 
measured using a heated pneumotach (Hans Rudolph, Kansas City, KS, USA – 
Chapter 6; Cosmed Quark CPET, Rome, Italy – Chapter 5), which was 
calibrated with a 3 L syringe before each testing session. Respiratory rate, tidal 
volume and minute ventilation were calculated online by the Spirometry module 
from Labchart (ADInstruments, Dunedin, New Zealand). For the measurement 
of the partial pressure of CO2, the nasal cannula or mask was connected to a 
capnograph which continuously sampled the gas (Moxus modular, AEI 
Technologies, Pittsburgh, PA, USA – Chapter 4; Cosmed Quark CPET, Rome, 
Italy – Chapter 5, RespSense, Nonin medical, Plymouth, MN, USA – Chapter 
6). In Chapter 4, the PETCO2 was derived from the relative percentage of 
expired CO2 as the maximum value at the end of the expiration, calculated as: 
                    , where PCO2 is the recorded relative percentage of 
CO2 and P0 is the atmospheric pressure measured on the day of the 
experiment. The devices in Chapters 5 and 6 already provided corrected partial 
pressures of CO2 and no calculation was required. 
3.2.2. Cerebral blood flow 
Transcranial Doppler ultrasound (Multidop X or Doppler BoxX, DWL, 
Sipplingen, Germany) acquired MCA Vmean was used as a surrogate index for 
the assessment of cerebral blood flow (Chapters 5 and 6) and volumetric 
cerebral blood flow was assessed at the ICAs and VAs with duplex Doppler 
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ultrasound (Sonos 7500 – Chapter 3 and iE33 – Chapter 4, Philips healthcare, 
Best, The Netherlands; Mindray M7, Shenzhen, GNG, China – chapter 5). 
The transcranial Doppler technique was performed using a 2 MHz pulsed wave 
transducer placed over the temporal window, a region superior to the zygomatic 
arch and anterior to the tragus where the temporal bone is less dense allowing 
the insonation of the MCA. The probe was fixed in place using an adjustable 
headgear and the interface between the probe and skin was made with 
ultrasound gel in order to transmit the waves directly from the probe to the skin 
reducing static. An optimal signal would then be acquired searching for a bright 
M-mode signal towards the probe, with a depth range from 40 to 65 mm. Gain 
and power would then be adjusted to allow for a high quality signal with minimal 
artifacts. The systolic, diastolic and mean blood flow velocity parameters were 
expressed in cm·s-1 and of the cerebral vascular conductance index (CVCi) was 
calculated as                   . 
Cerebral blood flow was measured with duplex Doppler technique using a 10 
MHz (7.5 MHz – Chapter 5) linear array transducer that was placed over the 
anterolateral surface of the sternocleidomastoid muscle with ultrasound gel as 
the interface between the probe and the skin. The arterial diameter was 
determined using bidimensional B-mode and was composed of the average 
over five to ten cardiac cycles (Figure 3.1). Images were stored for offline 
analysis and diameter was measured using the NIH ImageJ 1.49v software 
(Chapter 5), which has been widely used for a diverse range of applications 
including ultrasound (Schneider et al., 2012). The arterial diameter over each 
cardiac cycle was defined as the average of systolic and diastolic phases, with 
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three measurements being acquired during systole and three during diastole. 
ICA measurements were performed ≈1.5 cm distal from the bifurcation of the 
common carotid artery and VA measurements were performed between the 
transverse processes of C3 to C6.  
The blood velocity was acquired using the PW-mode and defined as the time 
averaged mean velocity over the cardiac cycle as calculated by the machine. To 
ensure the best possible velocity spectral waveform was captured, care was 
taken to maintain the Doppler angle between 30-60° from the direction of the 
flow, the sample volume width was adjusted to cover the width of the luminal 
diameter and appropriate setup of Doppler gain, angle correction and scales. 
Blood flow in each artery was calculated as: 
          
        
 
                
Total cerebral blood flow was calculated as the sum of the blood flow in both 
ICAs and both VAs. All ultrasound images, measurements and analyses were 
performed by the candidate (IDB). 
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3.2.3. Physical activity 
Physical activity was measured using an accelerometer (GT3X, Actigraph, 
Pensacola, FL, USA – Chapter 4). Participants were instructed about the 
placement of the device, and asked to wear them for 7 days. The accelerometer 
was able detect movement in 3 orthogonal planes and also measured the time 
spent in sedentary, mild, moderate, vigorous and very vigorous activity 
throughout the day. Counts of movement in each orthogonal plane were used to 
calculate tri-axial vector magnitude, total daily counts and steps. Physical 
activity levels were calculated by the Actigraph accelerometer software and 
defined as light (≤ 2.99 metabolic equivalents), moderate (3.0-5.99 metabolic 
equivalents), hard (6.0-8.99 metabolic equivalents), and very hard (≥ 9.0 
metabolic equivalents) as typically used in the literature (Freedson et al., 1998). 
The phenomenon of reactivity is when study participants change their normal 
behaviour when they are being monitored and may result in an overestimation 
Figure 3.1. Ultrasound images of the internal carotid and vertebral arteries. 
Internal carotid artery (Panel A, arrow) and vertebral artery (Panel B, arrow) as visualized 
by ultrasonography. Images acquired from the study presented in Chapter 5. 
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of ≈15% on the variable measured (McCarthy & Grey, 2015). However, the 
occurrence of this phenomenon is controversial (Behrens & Dinger, 2007) and, 
if present in the participants from Chapter 4, it is likely that both groups were 
affected equally. 
3.2.4. Cognition 
In Chapters 4 and 6, participants underwent cognitive screening using the 
Montréal Cognitive Assessment (MoCA). The MoCA aims to assess global 
cognitive function and is used to assess the major cognitive domains, being 
composed of visuospatial/executive, naming, memory, attention, language, 
abstraction and orientation tests (http://www.mocatest.org). It has a high 
sensitivity (0.89, 95% confidence interval of 0.84 to 0.92) and specificity (0.75, 
95% confidence interval of 0.62 to 0.85) to detect mild cognitive impairment 
(Tsoi et al., 2015). The MoCA is considered to have comparable performance 
against the most widely used global cognition assessment test, the mini-mental 
state exam (Tsoi et al., 2015). 
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3.3. Interventions 
3.3.1. Hypercapnic and hypocapnic tests 
The atmospheric relative content of CO2 is currently ≈400 parts per million 
(0.04%), and changes in arterial CO2 were required to allow the determination 
of hypercapnic or hypocapnic CVRCO2 in Chapters 5 and 6. In order to provoke 
hypercapnia, supplemental CO2 was added to the inspired normoxic air in 4% 
and 7% concentrations (Chapter 6, Figure 3.2) or dynamically adjusting the 
fraction of inspired CO2 to achieve a specific PETCO2 target (Chapter 5). In 
Chapter 5, this dynamic control of PETCO2 was performed manually as 
elsewhere in the literature (Verbree et al., 2014). Participants would be given 
supplemental CO2 to achieve an increase of +1.5 and +5.5 mmHg for 3 minutes 
in each step after a stable plateau was reached. This small increase in baseline 
(+1.5 mmHg) was performed as it has been shown to reduce the resting 
cerebral perfusion variability (Harris et al., 2006). In Chapter 6, Douglas bags 
were used to deliver increased inspired CO2 at concentrations of 4 % CO2 (≈21 
% O2) and 7 % CO2 (≈21 % O2) for 4 minutes in each step. These 
concentrations of gas have been previously used in the literature to assess 
cerebrovascular reserve (Ringelstein et al., 1988; Vernieri et al., 2004). This 
increase in the inspired fraction of CO2 caused hypercapnia without the 
potentially confounding presence of altered arterial O2, which happens when 
hypercapnia is achieved with breath-hold and rebreathing without oxygen 
supplementation. It is also an advantage over protocols that give gas mixtures 
with hyperoxia, as seen in studies using carbogen (usually 5% CO2 in 95% O2). 
Although widely used, caution is needed to interpret CVRCO2 tests when 
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monitoring cerebral perfusion with transcranial Doppler, as it has been shown 
that a ≈6.8% increase in MCA diameter was observed while the PETCO2 was set 
≈15 mmHg above the baseline (Verbree et al., 2014). If unaccounted for, this 
dilatation may underestimate in ≈14% the actual CVRCO2 in that artery. Although 
hypercapnic dilatation of the cerebral arteries insonated in CO2 reactivity tests 
using transcranial Doppler may result in an underestimation of the actual 
cerebral blood flow, this was not an issue in Chapter 5 as the main outcome 
variable was the blood flow thought the ICA. In Chapter 6, it is expected that 
this underestimation affected all groups with the same magnitude, and the 
statistical approach with multiple pairwise comparisons can reduce the clinical 
and physiological impact of this aspect of the test. Hypocapnic CVRCO2 
(Chapter 6) was achieved by asking the participant to hyperventilate in a 
controlled fashion, in order to maintain PETCO2 within a predetermined range 
that was defined as the same magnitude of change achieved by the 
hypercapnic steps, but in the hypocapnic range. Participants were continuously 
instructed to adjust their respiration by increasing or decreasing rate or depth in 
a similar way to the hypercapnic changes. 
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Figure 3.2. An original record of MCA V, blood pressure and PETCO2 responses to the 
hypercapnic and hypocapnic tests in one representative individual. 
MCA V, middle cerebral artery blood velocity; FiCO2, fraction of inspired CO2; PETCO2, 
partial pressure of end-tidal CO2. 
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3.3.2. Assessment of cerebral autoregulation 
A single sit-to-stand was performed to assess dynamic cerebral autoregulation 
(Chapter 6), in which the participant was instrumented, asked to rest 
comfortably seated and, after 5 minutes, the participant was asked to stand up 
in a single movement (Figure 3.3). This procedure evoked a drop in blood 
pressure which was coupled with a drop in cerebral blood velocity, and the 
ability of the cerebral circulation in maintaining the perfusion despite this drop in 
blood pressure is one aspect of the cerebral autoregulation. The MCA Vmean, 
MAP and PETCO2 were calculated as the average of the 20 s before the 
participant stood up for the baseline, while the response was the average value 
of the 5 cardiac cycles surrounding the nadir of the blood pressure. 
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Figure 3.3. An original record of MCA V, blood pressure and PETCO2 responses to the 
single sit-to-stand test in one representative individual. 
MCA V, middle cerebral artery blood velocity; PETCO2, partial pressure of end-tidal CO2. The 
red dashed line denotes the moment of standing. 
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Cerebral autoregulation was also assessed in a frequency-dependent manner, 
as slow oscillations in blood pressure (<0.2 Hz) are dampened by the cerebral 
vessels (Aaslid et al., 1989; Zhang et al., 1998). Higher frequency oscillations 
(>0.2 Hz) are transferred to the cerebral vasculature unimpeded, characterizing 
the cerebral autoregulation as a high-pass filter (Smirl et al., 2016). Transfer 
function analysis (TFA) is the most widely used method for this assessment and 
recent guidelines were published in an attempt to standardize this approach 
(Claassen et al., 2016). TFA is usually computed using a fast Fourier transform 
to quantify the relationship between input (MAP) and output (MCA Vmean) 
signals with respects to amplitude (gain), timing (phase) and their linear 
association (coherence). A lower gain is usually indicative of better buffering of 
changes in MAP by the cerebral vasculature, but it can also suggest a greater 
cerebral vascular resistance (Claassen et al., 2009). Phase (also called phase 
shift or phase lead) is representative of the delay between input and output, and 
a phase shift close to zero in the lower frequency range may indicate an 
impaired autoregulation (van Beek et al., 2008). Coherence is a measure of the 
linearity of the relationship between input and output signals, and low 
coherence values (typically <0.5) may indicate: 1) nonlinear relationship 
between input and output; 2) poor signal-to-noise ratio; and 3) presence of other 
factors influencing the output parameter (Panerai et al., 2006; van Beek et al., 
2008). As TFA requires equidistant data points, beat-by-beat data undergo 
cubic polynomial interpolation and resampling at 10 Hz. To improve the spectral 
estimations, the Welch method is used to smooth the data after it is broken 
down using Hanning tapered windows to prevent spectral leakage. Segments of 
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data are superimposed by 50% in order to maximise smoothing. Then, auto- 
and cross-spectral analysis between MAP and MCA Vmean are used to derive 
gain, phase and coherence between the signals. MCA Vmean and MAP spectral 
power, gain, phase and coherence were averaged over the very low frequency 
(0.02–0.07 Hz), low frequency (0.07–0.2 Hz) and high frequency (0.2–0.5 Hz) 
ranges as recommended by current guidelines (Claassen et al., 2016). 
A low coherence may compromise the assessment of gain and phase, therefore 
manoeuvres such as repeated squats can be employed to increase coherence, 
and arguably allow a better interpretation of TFA (Claassen et al., 2009). In this 
thesis, participants were requested to perform a repeated squat-to-stand after a 
baseline period of 2 minutes standing. The squat-to-stand protocol consisted of 
5 s squatting with the knees bent at ≈90°, followed by 5 s standing straight (i.e. 
at a frequency of 0.1 Hz), a process which was repeated for 5 minutes. During 
the squat phase, contraction of the leg muscles causes an increase in blood 
pressure due to an increased venous return by the muscle pump and increased 
resistance caused by compression of the surrounding vessels. When standing, 
the reduction in venous pressure at the legs causes blood to pool in the lower 
extremities, which generates a reduction in blood pressure. These cyclic 
changes in blood pressure lead to an increased coherence which optimizes the 
TFA analysis at that frequency range. Typical recordings are presented in 
Figure 3.4. 
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Figure 3.4. An original record of MCA V, blood pressure and PETCO2 responses to the 
repeated squat-to-stand test in a representative individual. 
MCA V, middle cerebral artery blood velocity; PETCO2, partial pressure of end-tidal CO2. 
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3.4. Data acquisition and analysis 
In all studies, signals from haemodynamic, respiratory variables and 
transcranial Doppler were sampled by a high-performance data acquisition 
hardware (Powerlab, ADInstruments, Dunedin, New Zealand) at 1 kHz and 
recorded using a multi-channel data acquisition software (Labchart 7 and 8, 
ADInstruments, Dunedin, New Zealand). The acquired data were then 
transferred to a digital spreadsheet (Excel 2010 and 2013, Microsoft, Redmond, 
WA, USA), where the beat-by-beat data was converted into averages for each 
time point. Statistical analysis was performed using scientific data analysis and 
graphing software (SPSS 22, IBM, Armonk, NY, USA – Chapters 3 and 4 or 
Sigmaplot 12.5, Systat software, London, UK – Chapters 4, 5 and 6). Normality 
was assessed with the Shapiro-Wilk test and non-normally distributed data 
underwent log10 transformation. If after the log10 transformation the data was 
still non-normally distributed, a non-parametric test was used. The statistical 
approach used for each variable is described in the methods section of each 
chapter. Statistical significance was set at p < 0.05 to all tests performed. 
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3.5. Reliability of the methods 
In order to assess if the methodology described above can be used in future 
studies aiming interventions to improve the described parameters (i.e. repeated 
measures), it is essential that the results obtained are reproducible and reliable 
in the laboratory where the assessment is taking place. Although the 
reproducibility of the duplex Doppler techniques were reported to be good at 
rest (Schoning & Scheel, 1996), training and appropriate assessment of the 
reliability of the examiner prior to the use of a technique in research is 
warranted. This section aims to assess the between-day reliability of the 
cerebral blood flow measurement used in the studies described in Chapters 4 
and 5. 
Measurements were performed in healthy young individuals (age range from 21 
to 32 years) in two separate occasions at the same time of the day, at least 24 
hours apart. Participants were asked to refrain from caffeinated beverages, 
alcohol or high intensity physical activity for 12h prior to the test. On the study 
day, the participant was positioned supine, resting comfortably in a bed with 
external noise kept to a minimum. Agreement between the two measurements 
was assessed using intraclass correlation coefficient with a one-way analysis of 
variance (ANOVA) random model (Shrout & Fleiss, 1979), coefficient of 
variation (CV) and Bland-Altman plots (Bland & Altman, 1986). The CV was 
calculated in Excel, as:          , where SD is the standard deviation of the 
sample and   is the sample mean. 
62 
 
3.5.1. Doppler ultrasound of the extracranial vessels 
Doppler ultrasound assessment of 19 arteries (9 ICAs and 10 VAs) was 
performed in two occasions as described above and stored for offline analysis. 
Arterial diameter was measured using the device calliper function and the time 
averaged mean blood velocity was calculated by the machine. Blood flow in 
each artery was calculated as described previously. The overall correlation 
between days was very high, with an intraclass correlation coefficient of 0.934 
(95% CI 0.756 to 0.985) for the ICAs and 0.947 for the VAs (95% CI 0.812 to 
0.986), and the CV showed acceptable results at 19.5% at the ICAs and 14.5% 
at the VAs. The Bland-Altman plots (Figure 3.5) also show a good agreement, 
with a mean difference of -11.87 mL · min-1 and limits of agreement ranging 
from -79.65 to 55.92 mL · min-1 at the ICAs and a mean difference of -2.58 mL · 
min-1 and limits of agreement ranging from -34.27 to 29.11 mL · min-1 at the 
VAs. 
 
Figure 3.5. Bland-Altman plots of the between days reproducibility of flow measurements. 
The between days reproducibility in blood flow is shown at the ICA (panel A) and at the VA 
(panel B). Dashed lines indicate the mean of the differences and limits of agreement.  
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3.5.2. Conclusions 
In this thesis, the assessment of cerebral blood flow via ultrasonography of the 
extracranial vessels ICA and VA was shown to be reliable, with substantial 
agreement between days, and have variability parameters within expected limits 
in all arteries measured (Quan & Shih, 1996). PETCO2 was not measured during 
this assessment and may account for some of the measurement variability.  
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CHAPTER 4: INFLUENCE OF DAILY PHYSICAL ACTIVITY ON 
CEREBRAL BLOOD FLOW IN HEALTHY OLD INDIVIDUALS 
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4.1. Introduction 
The global population has recently experienced an unprecedented increase in 
life expectancy, and the segment of the population aged more than 60 years is 
expected to increase the most, from 871 million people in 2013 to more than 2 
billion by 2050 (United Nations, 2013). Even in the absence of disease, ageing 
is associated with detrimental changes in brain structure and function (Scahill et 
al., 2003; Burgmans et al., 2011), and it is one of the most important non-
modifiable risk factors for cerebral vascular disease, cognitive decline and 
dementia (Lindsay et al., 2002; Bos et al., 2012). The ageing process is coupled 
with a reduction in cerebral blood flow in grey and white matters that can be as 
much as 0.5 % per year during adult life (Leenders et al., 1990). This reduction 
has been proposed to be linked to the age-related decrease in cerebral mass or 
neuronal density (Kety, 1956; Leenders et al., 1990), although the exact 
mechanisms for the cerebral blood flow decline due to the healthy ageing 
process remain unknown. 
Physical inactivity increases the burden of disease, contributing to ≈9% of the 
overall premature mortality and to the loss of life expectancy with conditions 
such as coronary heart disease, diabetes and cancer (Lee et al., 2012). Regular 
physical activity is a well-known strategy to reduce the age-related decline in 
physical (Chodzko-Zajko et al., 2009) and mental (Paillard, 2015) function, 
although the mechanisms of this protection are not fully understood. Animal 
studies show that an increase in the number of new hippocampal cells (van 
Praag et al., 1999) and enhanced cerebellar vascularization (Black et al., 1990) 
were associated with physical activity in rats. Furthermore, exercise, which is a 
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planned and structured form of physical activity, has also been associated with 
increased synaptogenesis, as exercising rats had increased dendritic 
complexity and number of dendritic spines when compared to control animals 
(Eadie et al., 2005). However, some cerebral adaptations to chronic exercise 
training, such as the functional connectivity in cerebral association networks, 
are independent of physical activity levels (Voss et al., 2016). This may 
implicate that different mechanisms can be stimulated by high levels of physical 
activity and cardiorespiratory fitness. In general terms, molecular messengers 
proposed to mediate these changes include brain-derived neurotrophic factor, 
insulin-like growth factor 1, uncoupling protein 2, and neurotransmitters such as 
serotonin, noradrenalin and acetylcholine (Lista & Sorrentino, 2010). 
Human studies show that higher physical activity is associated with an 
improvement in several cognitive areas, such as working memory, attention and 
task-switching (Kramer et al., 1999; Weuve et al., 2004), although the 
mechanisms are still unclear. In one study with 18766 women, participants in 
the highest quintile of physical activity (> 26 metabolic equivalent · h · wk-1), had 
a 20 % lower risk of cognitive impairment when compared to the ones in the 
lowest physical activity quintile (< 5.2 metabolic equivalent · h · wk-1) (Weuve et 
al., 2004). It has been shown that a one year walking intervention increased the 
neuronal connectivity between cognitive-related areas such as the fronto-
temporal cortices in humans (Voss et al., 2010). It has been previously 
demonstrated that old individuals that keep working or remain physically active 
after reaching retirement age have higher cerebral blood flow and superior 
cognition when compared to sedentary retired individuals (Rogers et al., 1990). 
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Furthermore, old individuals who are highly aerobically fit are reported to have 
higher cerebral perfusion than their untrained counterparts (Ainslie et al., 2008; 
Bailey et al., 2013b), although it has also been shown that a high 
cardiorespiratory fitness was associated with a reduced cerebral vasodilatory 
reserve (Thomas et al., 2013). Despite being methodologically sound, the 
choice of recruiting highly fit individuals (Ainslie et al VO2max: 52.4 
ml·kg−1·min−1, Bailey et al VO2max: 39 ml·kg
−1
·min−1, Thomas et al VO2max: 
40.6 ml·kg−1·min−1) may not be representative of the general population, limiting 
the findings to this specific group. On the other hand, the studies with less fit but 
still active individuals assessed physical activity using questionnaires (Rogers et 
al., 1990; Weuve et al., 2004), and as these self-assessment tools were not 
objectively validated, discrepancies between the report and the actual physical 
activity levels may limit the interpretation of these findings (Shephard, 2003). 
Understanding how daily physical activity influences cerebral blood flow is 
important to identify the mechanisms by which it confers protection against 
cognitive decline and dementia. This Chapter aimed to determine the influence 
of objectively measured daily physical activity on the cerebral blood flow using 
duplex Doppler ultrasound and cognition in a cohort of community dwelling 
healthy old individuals. This study tested the hypothesis that physically active 
individuals would have higher cerebral blood flow and cognition than their 
inactive counterparts. 
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4.2. Methods 
All the procedures performed in this study were approved by the National 
Research Ethics Service Committee West Midlands - Black Country 
(10/H1202/77) and conformed to the declaration of Helsinki. Potential 
participants were given an information sheet and a detailed verbal explanation 
of the tests. If satisfied with the explanation and given the opportunity to ask 
questions about the procedures, volunteers would provide written informed 
consent to participate in the study. This study is a part of a larger study that 
assessed cardiovascular and immune system function in a cohort of healthy 
elderly individuals (Bartlett et al., 2016). 
4.2.1. Cohort characteristics 
Participants were recruited from a cohort of 217 healthy individuals aged 60-80 
years. After written informed consent was obtained, participants were screened 
at the Wellcome Trust Clinical Research Facility, Birmingham, UK for their blood 
glucose (Accu-Chek Performa, F. Hoffmann-La Roche AG, Basel, Switzerland) 
which excluded 6 participants due to possible undiagnosed dysglycemic 
pathology. Participants were free from diabetes, neurologic, cerebral vascular, 
heart, liver, inflammatory disease, or cancer. Physical activity was assessed by 
7-day accelerometry (GT3X, Actigraph, Pensacola, FL, USA). Participants wore 
the accelerometer around the waist above the left leg, except for water based 
activities such as showering and swimming, 24 h/day for 7 consecutive days 
and the numbers of daily steps, counts, vectors and time in each intensity of 
physical activity were calculated. The participants were then grouped in physical 
activity quintiles according to the accelerometry data, and participants from the 
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least (n = 16, low physical activity group) and most (n = 17, high physical 
activity group) physically active quintiles were recalled for further assessment, 
as detailed below. 
4.2.2. Measured variables 
On a separate visit to the laboratory, blood pressure and heart rate (Dinamap 
ProCare 200, GE Medical Systems, Milwaukee, WI, USA) were measured after 
at least 5 minutes of resting in a supine position. Cognition was determined with 
the MoCA. A nasal cannula was connected to a capnograph (Moxus modular, 
AEI Technologies, Pittsburgh, PA, USA) to measure PETCO2. Arterial diameter 
and time averaged mean blood velocity at the ICAs and VAs were assessed 
bilaterally using duplex Doppler ultrasound (iE33, Philips Healthcare, Best, the 
Netherlands). The blood flow in each artery was calculated as described in 
section 3.2.2. 
Global cerebral blood flow was the result of the sum of the bilateral ICAs and 
bilateral VAs blood flow. Due to insufficient image quality, 3 participants were 
excluded from the final analysis, resulting in 14 participants on the low physical 
activity group and 16 participants on the high physical activity group. 
4.2.3. Data analysis 
Capnograph data was recorded digitally and stored for offline analysis 
(Powerlab and LabChart Pro, ADInstruments, Dunedin, New Zealand) and 
ultrasound data was stored and analysed offline (Xcelera, Philips healthcare, 
Best, The Netherlands). 
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4.2.4. Statistical analysis 
Normality was assessed with the Shapiro-Wilk test, and non-normal data was 
log10 transformed to achieve normal distribution. Independent samples t-tests 
were used for between groups comparisons and significance was set on α = 
0.05. Mann-Whitney U test was used to analyse the cognition and non-normally 
distributed data. Statistical analysis was performed using the SPSS software 
(version 22, IBM, Armonk, NY, USA) and results are presented as mean (95% 
confidence interval). 
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4.3. Results 
Participant characteristics are presented in Table 4.1. There were no significant 
differences in age, blood pressure, heart rate, PETCO2 or MoCA score between 
the low and high physical activity groups. Accelerometry data is presented in 
Table 4.2. The low physical activity group was on average ≈55% less active 
than the high physical activity group when assessed by the number of daily 
steps. The time over the 7-day period spent in moderate activity (from 3 to 5.99 
metabolic equivalents) in the low physical activity groups was 107 (69-145) min 
while the high physical activity group spent 382 (258-505) min (p < 0.001) over 
the 7 days. Four participants (2 low and 2 high physical activity group) did not 
complete the 7-day period (range: 4 to 6 days) and were excluded from this 
analysis. 
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Table 4.1. Participants characteristics 
  Low activity High activity   
t and p-
value 
Age (years) 68 (65-71) 66 (65-68)  
t(28) = 0.85 
p = 0.400 
Sex 
(males/females) 
7 / 7 7 / 9  - 
Height (cm) 169 (163-174) 169 (163-174)  
t(28) = 0.01 
p = 0.995 
Weight (kg) 75 (65-85) 68 (62-73)  
t(28) = 0.30 
p = 0.766 
BMI (kg·m-2) 26 (24-29) 24 (22-26)  
t(28) = 1.80 
p = 0.084 
SBP (mmHg) 133 (122-144) 126 (119-133)  
t(28) = 1.12 
p = 0.272 
DBP (mmHg) 77 (71-82) 77 (73-81)  
t(28) = 0.01 
p = 0.989 
MAP (mmHg) 96 (89-102) 93 (88-98)  
t(28) = 0.58 
p = 0.568 
HR (bpm) 65 (59-72) 68 (63-73)  
t(28) = -0.64 
p = 0.525 
PETCO2 (mmHg) 35 (33-36) 35 (33-36)  
t(28) = 0.22 
p = 0.827 
MoCA (score)* 27 (25.5-29) 26.5 (25-28)  
U = 95.0 
p = 0.498 
SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; HR, 
heart rate; PETCO2, partial pressure of arterial carbon dioxide; MoCA, Montréal Cognitive 
Assessment. Values are reported as mean (95% confidence interval). *Reported as median 
(interquartile range). 
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Table 4.2. Physical activity as measured by 7-day accelerometry 
  Low activity High activity   t and p-value 
Daily steps (n) 4923 (4168-5677) 11063 (9445-12681)  t(28) = -7.90, p < 0.001 
Daily counts (x1000) 614 (558-670) 1400 (1287-1513)  t(28) = -14.49, p < 0.001 
Daily vectors (x1000) 361 (328-394) 820 (755-885)  t(28) = -12.89, p < 0.001 
Validated time in light PA (min) 285 (217-352) 719 (627-811)  t(28) = -7.97, p < 0.001 
Validated time in moderate PA (min) 107 (69-145) 382 (258-505)  t(28) = -4.29, p < 0.001 
Validated time in vigorous PA (min)* 0 (0-0.5) 2.5 (0-33.5)  U = 57.50, p = 0.013 
PA, physical activity. Values are reported as mean (95% confidence interval). *Reported as median (interquartile range). 
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As presented in Figure 4.1, global cerebral blood flow was not significantly 
different between low and high physical activity groups. Low physical activity 
group had a bilateral ICA flow of 617 (515-719) mL · min-1 while in the high 
physical activity group, bilateral ICA flow was 595 (500-690) mL · min-1 with no 
significant difference between groups (t(28) = 0.84, p = 0.408). Similarly, the 
bilateral VA flow was 211 (168-253) mL · min-1 on the low physical activity 
group and 193 (165-221) mL · min-1 on the high physical activity group with no 
significant difference between groups (t(28) = 0.74, p = 0.463). The relative 
contribution of the bilateral ICA to the global cerebral blood flow was similar 
between groups with 75 (71-79) % in the low physical activity group and 75 (71-
78) % in the high physical activity group (t(28) = 0.23, p = 0.820). Table 4.3 
shows the mean diameter and flow velocities from each measured artery. 
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Figure 4.1. Global and regional cerebral blood flow (CBF) in low and high physical activity 
groups. 
Low, low physical activity group; High, high physical activity group; CBF, cerebral blood 
flow; ICA, internal carotid artery; VA, vertebral artery 
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Table 4.3. Arterial diameter and blood velocity measured in the internal carotid and vertebral 
arteries 
  Low activity High activity   t and p-value 
R ICA diameter (cm) 0.55 (0.09) 0.48 (0.09)  
t(28) = 1.96 
p = 0.060 
R ICA Vmean (cm · s
-1) 25.7 (9.0) 26.7 (6.5)  
t(28) = -0.35 
p = 0.728 
R VA diameter (cm) 0.36 (0.05) 0.33 (0.05)  
t(28) = 1.58 
p = 0.124 
R VA Vmean (cm · s
-1) 15.2 (4.8) 16.1 (5.1)  
t(28) = -0.48 
p = 0.637 
L ICA diameter (cm) 0.49 (0.09) 0.47 (0.06)  
t(28) = 0.104 
p = 0.412 
L ICA Vmean (cm · s
-1) 24.0 (4.8) 28.5 (7.3)  
t(28) = -1.88 
p = 0.070 
L VA diameter (cm) 0.38 (0.07) 0.37 (0.05)  
t(28) = 0.24 
p = 0.811 
L VA Vmean (cm · s
-1) 16.9 (5.9) 16.5 (5.0)  
t(28) = 0.20 
p = 0.842 
R, right; L, left; ICA, internal carotid artery; VA, vertebral artery; Vmean, mean blood velocity. 
Values are reported as mean (SD).  
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4.4. Discussion 
This study aimed to assess the influence of objectively measured daily physical 
activity on cerebral blood flow using duplex Doppler ultrasound and cognition in 
a cohort of community dwelling healthy old individuals. Although the high 
physical activity group was more than twice as active as the low physical activity 
group, no difference in global cerebral blood flow or regional differences as 
measured at the ICAs and VAs was observed. Furthermore, a higher degree of 
daily physical activity did not significantly affect cognition in this population. 
Regular physical activity and exercise are known to reduce the risk for cerebral 
vascular disease and dementia (Pearson et al., 2002; Larson et al., 2006). 
Current guidelines recommend that old individuals (men and women aged 65 
years or more) perform at least 150 minutes per week of moderate intensity 
aerobic exercise in addition to strength-enhancing exercise (Nelson et al., 2007; 
Garber et al., 2011). The guidelines also suggest that greater amounts of 
activity may provide additional health benefits, reducing the risk of 
cardiovascular death, cerebrovascular disease, anxiety and depression, and 
should be recommended in all who are not limited by health conditions to 
perform more exercise (Nelson et al., 2007). It has been shown that there is an 
inverse linear dose-response relation between physical activity and all-cause 
mortality (Lee & Skerrett, 2001), although the mechanisms underpinning 
exercise-related improvements in systemic and cerebral protection are not fully 
understood. 
Sedentary behaviour leads to a pro-inflammatory state caused by accumulation 
of visceral adiposity, facilitating the atherosclerotic degeneration of the arterial 
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walls (Szostak & Laurant, 2011). In fact, animal studies show that after eleven 
generations of selective breeding in rats, a lower aerobic capacity increased 
blood pressure, fasting glucose, insulin, visceral adiposity and triglycerides 
while essential proteins for mitochondrial metabolism such as peroxisome 
proliferative activated receptor γ and ATP synthase H+-transporting 
mitochondrial F1 complex, among others, were markedly reduced, supporting 
the idea that an impaired mitochondrial oxidation pathway may explain some of 
the metabolic risk profile of sedentary animals (Wisløff et al., 2005). In addition, 
ageing vessels are known to generate excess reactive oxygen species, 
peroxides and superoxides mainly by mitochondrial respiratory chain 
production, which contribute to an impaired endothelial function (El Assar et al., 
2013). Exercise has been shown to contribute to a reduced oxidative stress 
(Miyazaki et al., 2001), and improve systemic arterial function via mechanisms 
including NO (DeSouza et al., 2000) and arterial compliance (Ashor et al., 
2014). Furthermore, it has been proposed that exercise improves the cerebral 
vasculature by stimulating the production of endothelial progenitor cells, 
optimizing the shear stress and NO vasodilatory pathways, enhanced 
sympathetic nervous system activation stimulating angiogenesis and reducing 
the mechanical load in arteries by a lower heart rate (reviewed in (Bolduc et al., 
2013). However, the mechanisms responsible for the improvement of cerebral 
vascular function with exercise are still unclear. 
Maintaining a high cardiorespiratory fitness throughout life has been shown to 
offset the age-related decline in cerebral perfusion by approximately 17% 
(Ainslie et al., 2008). In addition, studies showed that cerebral vasodilatory 
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reserve appears to be associated with cardiorespiratory fitness in old individuals 
(Bailey et al., 2013b; Barnes et al., 2013). However, other studies showed that 
cardiorespiratory fitness had no effect or even reduced CVRCO2 in trained old 
individuals when compared to their sedentary peers (Thomas et al., 2013; Zhu 
et al., 2013). This highly controversial topic is the subject of the following thesis 
Chapter. Although several studies assessed the cerebral perfusion and its 
regulation comparing old trained and untrained individuals (Ainslie et al., 2008; 
Bailey et al., 2013b; Thomas et al., 2013; Flück et al., 2014), the impact of daily 
physical activity on the cerebral blood flow of untrained healthy community-
dwelling old individuals who are considered active or sedentary as per current 
guidelines is still unclear. Previous studies assessed cardiorespiratory fitness 
through VO2max tests (Ainslie et al., 2008; Bailey et al., 2013b; Flück et al., 
2014) or questionnaires (Rogers et al., 1990; Weuve et al., 2004). Although 
these techniques may be useful for assessing cardiovascular fitness or 
sedentary behaviour, the assessment of the optimal physical activity levels in 
late life as recommended by current guidelines is not possible. Questionnaires 
provide a low-cost easy solution to assess physical activity, but they may 
provide unreliable estimates of low-to-moderate intensity physical activities such 
as walking (Ainsworth et al., 1993; Richardson et al., 1994). On the other hand, 
the use of accelerometry provides not only the number of steps, counts and 
vectors, but also the time in moderate and vigorous activity that can be 
quantified and assessed comparing to current guideline recommendations. 
Although accelerometers are reported to correlate well with doubly labelled 
water or calorimetric methods (Westerterp, 1999), weaknesses of this method 
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include the cost and the fact that it is not sensitive to all kinds of activity such as 
swimming (due to lack of waterproofness in some models) or upper body 
exercise. Despite these weaknesses, accelerometers are considered a sound 
option for the assessment of physical activity in a population (Tudor-Locke & 
Myers, 2001). Only two participants in the low physical activity group from this 
study reached the minimum physical activity level as recommended, while all in 
the high physical activity group met the guideline recommendations. Thus, this 
study suggests that the difference in daily physical activity levels from 
community-dwelling healthy individuals in this cohort, albeit substantial, was not 
enough to impact resting global cerebral blood flow or the distribution of 
cerebral blood flow between the ICAs and VAs. 
Previous studies have reported that cognition is lower in old sedentary 
individuals when compared to their physically active counterparts (Rogers et al., 
1990; Weuve et al., 2004). In a study with 18766 women aged 70 to 81 years, 
women on the highest quintile of physical activity as measured by mailed 
questionnaires had a 20% lower risk of cognitive impairment when compared to 
the women on the lowest quintile (Weuve et al., 2004). Cognition was assessed 
using telephone interview for cognitive status, which is based on the mini 
mental state exam, and the east Boston memory test.  Furthermore, Rogers et 
al (1990) have reported that in 83 old individuals (62 to 70 years), those who 
stayed physically active or kept working after reaching retirement age had 
higher cognitive capacity screening exam scores than their inactive retired 
counterparts after a 4-years follow-up. Working and physically active 
participants also had a stable cerebral blood flow, while their sedentary 
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counterparts significantly declined over time as measured by the [133Xe] 
technique. Serum cholesterol profile (Cheng et al., 2014), arterial stiffness 
(Cooper et al., 2016), endothelial function (Vendemiale et al., 2013) and other 
are potential mechanisms contributing to cognitive decline in ageing, and 
exercise may be used as a means of counteracting these risk factors. High total 
cholesterol levels are known risk factors for dementia (Solomon et al., 2009), 
and this association may be due to increased plasma homocysteine causing 
blood-brain barrier leakage and favouring inflammation (Cheng et al., 2014). 
Stiffening of the large arteries may lead to microvascular damage due to 
excessive pulsatility, which increases the risk of cerebral damage and cognitive 
impairment (Cooper et al., 2016). Furthermore, endothelial dysfunction may be 
present even in the early stages of cognitive decline, reducing the cerebral 
vasodilatory reserve, which in turn may lead to an inadequate response to 
cerebral demand for nutrients (Vendemiale et al., 2013). Physical activity may 
help improve cerebral vascular function and reduce cognitive decline by 
improving blood lipids profile, reducing arterial stiffness and improving 
endothelial function, thus counteracting many of the proposed mechanisms for 
the cognitive decline (DeSouza et al., 2000; Ashor et al., 2014; Paillard, 2015). 
However, the results from this chapter did not show any difference in cognition 
between the high and low physical activity groups. One reason for this finding is 
that this study may be underpowered to assess cognition using the MoCA. 
Previous projects estimated that to detect a difference on a MoCA score of 1.5 
between 2 groups would require 52 participants per group (Boss et al., 2014). 
Another important limitation for this analysis is that this study is cross-sectional, 
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and results should be interpreted cautiously. Lifelong physical activity was not 
assessed, and the measured levels could be over or underestimating previous 
physical activity levels. This may limit the interpretation of the findings 
presented as participants might have long-term cerebral vascular adaptations of 
exercise even if they were allocated in the low physical activity group due to 
late-life change in physical activity habits. Furthermore, retirement was not 
assessed by this study, and interpretation of the findings in this Chapter should 
consider this limitation. 
In conclusion, this study suggests that daily physical activity did not influence 
cerebral blood flow in this cohort of healthy old individuals. Although cognition 
was similar between groups, this study may have been underpowered to allow 
proper significance of the cognitive assessment findings. The use of 
instruments to assess specific areas of cognition affected by sedentary 
behaviour may be warranted in future studies. Higher levels of aerobic exercise 
might be required to promote substantial effects on the resting cerebral blood 
flow in healthy old individuals. Furthermore, this study assessed a very healthy 
sample which may not be representative of the majority of the ageing 
population, as the prevalence of disease is high. However, this study aimed to 
assess the effects of physical activity and age per se on the cerebral blood flow, 
which requires exclusion of confounding factors such as disease. Studies with 
people with chronic diseases are warranted to investigate the effect of daily 
physical activity in a more clinically diverse population. 
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CHAPTER 5: IMPACT OF AEROBIC FITNESS ON CEREBRAL 
BLOOD FLOW AND CEREBRAL VASCULAR 
RESPONSIVENESS TO CO2 IN YOUNG AND OLDER MEN 
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This Chapter was published in the Scandinavian Journal of Medicine and 
Science in Sports (Braz et al., 2016) and suffered minor modifications to adapt 
to the thesis format. 
5.1. Abstract 
This study sought to test the hypothesis that brain blood flow and CVRCO2 are 
greater in aerobically trained young and old individuals compared to their 
untrained counterparts. In eleven young trained (23 (20 to 26) yr [mean (95% 
confidence interval)]), ten young untrained (25 (22 to 28) yr, eight older trained 
(65 (61 to 69) yr, and nine older untrained (67 (64 to 71) yr healthy individuals, 
Doppler ultrasound of the internal carotid (ICA) and vertebral (VA) artery blood 
flow were determined, along with middle cerebral artery mean flow velocity 
(MCA Vmean). Bilateral ICA blood flow was higher in trained individuals when 
compared to untrained (≈31%, p < 0.05), but was not influenced by age. VA 
blood flow was not affected by age or cardiorespiratory fitness. MCA Vmean was 
reduced with age (59.5 (55.0 to 64.1) cm·s-1 young vs. 43.6 (38.4 to 48.9) cm·s-
1 old, p < 0.05) with no significant effect of training observed. MCA CVRCO2 
were not significantly affected by either age or training status, while ICA CVRCO2 
tended to be elevated in the old trained group. These findings indicate that 
endurance training enhances bilateral ICA but not VA blood flow in both young 
and older individuals. 
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5.2. Introduction 
An unprecedented increase in life expectancy and global population ageing has 
occurred over the last few decades (Salomon et al., 2012). Age is one of the 
most important non-modifiable risk factors for cerebral vascular disease (Bos et 
al., 2012) and dementia (Lindsay et al., 2002), and associated with changes in 
brain structure (Scahill et al., 2003), chemical signaling and function (Burgmans 
et al., 2011). However, other modifiable risk factors such as diet (Gomez-Pinilla, 
2008) and habitual physical activity (Hillman et al., 2006) may also have an 
impact on brain health. 
Exercise training improves cognitive task performance and reduces the 
morphological and cellular decline of the brain in ageing animal models (van 
Praag et al., 2005). While in elderly humans, exercise training reduces the loss 
of brain volume (Colcombe et al., 2006), improves mental function (Erickson et 
al., 2011) and enhances cerebral vasomotor reactivity (Bailey et al., 2013b; 
Barnes et al., 2013) although the latter remains controversial (Thomas et al., 
2013; Zhu et al., 2013).  
The cerebral circulation is highly responsive to changes in the PaCO2 (Kety & 
Schmidt, 1948a) and as a consequence CVRCO2 is frequently used to provide 
an indication of general cerebrovascular health (Gupta et al., 2012). There is 
accumulating evidence to suggest that CVRCO2 is impaired in 
neurodegenerative conditions such as Alzheimer’s disease (Glodzik et al., 
2013), Parkinson’s disease (Zamani et al., 2011) and chronic traumatic brain 
injury (Bailey et al., 2013a) and may increase the risk of death by any cause 
(Portegies et al., 2014). The influence of healthy ageing on CVRCO2 remains 
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equivocal, with evidence for (Bailey et al., 2013b; Barnes et al., 2013) and 
against (Kastrup et al., 1998; Oudegeest-Sander et al., 2014) the concept that 
age may impair CVRCO2. Furthermore, there is also contradictory evidence with 
respect to whether aerobic capacity influences CVRCO2 in elderly individuals. 
While some studies have reported an enhanced CVRCO2 in participants with 
higher aerobic capacity (Bailey et al. 2013; Barnes et al. 2013), other studies 
show that aerobic fitness has a negative or minimal impact on CVRCO2 (Thomas 
et al. 2013; Zhu et al. 2013). One potential limitation of the majority of these 
studies is that the transcranial Doppler technique was employed to assess 
CVRCO2 (Bailey et al. 2013; Barnes et al. 2013; Zhu et al. 2013). While this 
technique has a number of advantages, without an accurate measure of middle 
cerebral artery diameter it can only be assumed that increases in blood velocity 
are proportional to increases in cerebral blood flow. This is pertinent because 
recent studies have challenged this assumption and middle cerebral artery 
dilation has been reported in hypercapnic tests (Coverdale et al. 2014; Verbree 
et al. 2014). An alternative approach is to assess the CVRCO2 of the extracranial 
vessels (ICA, internal carotid artery; VA, vertebral artery) as this permits the 
concurrent volumetric quantification of cerebral blood flow (Willie et al. 2012). In 
addition, anatomical and functional differences within the anterior and posterior 
cerebral circulations, such as neurotransmitter signaling, sympathetic 
innervation (Edvinsson et al. 1976; Hamel et al. 1988) and responsiveness to 
CO2 (Reinhard et al. 2008), may result in regional differences (i.e. ICA vs VA) in 
the vascular adaptations to exercise training. However, the influence of age and 
aerobic exercise training on the extracranial blood vessels remains unclear.   
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The aim of this study was to investigate if age and cardiorespiratory fitness 
influence resting cerebral blood flow and CVRCO2. To achieve this, in sedentary 
and aerobically trained young and old individuals bilateral ICA and VA blood 
flow were measured, and ICA blood flow was determined in response to a 
hypercapnic challenge (i.e., CVRCO2). This study tested the hypothesis that 
bilateral ICA and VA blood flow and CVRCO2 would be greater in aerobically 
trained young and old individuals compared to their untrained counterparts.  
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5.3. Methods 
All experimental protocols and procedures were approved by the ethical 
committee of the Swiss Federal Institute of Technology Zurich (EK 2013-N-17) 
and conformed to the Declaration of Helsinki. Written informed consent was 
obtained from all participants after they had received a detailed verbal and 
written explanation of the study. Twenty-one young and twenty-four older males 
were recruited to the study and underwent screening by a physician to identify 
any cardiovascular, pulmonary, metabolic or neurological disease or use of 
medications. Seven older volunteers were excluded after the health screening. 
Cardiorespiratory fitness was first determined via self-assessment and 
confirmed through measurement of VO2max during an incremental exercise test 
to volitional exhaustion on a cycle ergometer while monitored by a physician 
(described below). In total twelve young trained, eleven young untrained, eight 
older trained and nine older untrained individuals took part in the study. 
Participants were requested to abstain from strenuous physical activity for 24 h, 
alcohol and caffeine for 12 h prior to experimental sessions. This study was 
conducted along with another investigation that tested a different hypothesis 
(Flück et al., 2014).  
5.3.1. Measurements 
HR was monitored using a lead II electrocardiogram and beat-by-beat MAP 
obtained from the middle finger of the left hand (Portapres, Finapres Medical 
Systems, Amsterdam, The Netherlands). PETCO2 was monitored on a breath-
by-breath basis through a face mask connected to a two-way valve (Hans 
Rudolph, Kansas City, USA) and respiratory analyzer (Cosmed Quark CPET, 
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Rome, Italy) and MCA Vmean by transcranial Doppler ultrasonography (Doppler 
Box, DWL, Sipplingen, Germany) using a 2 MHz probe fixed on the temporal 
window using an adjustable headband and ultrasound gel. Signals were 
sampled at 1 kHz and recorded for offline analysis using an analog-to-digital 
converter and data acquisition software (Powerlab and LabChart Pro, 
ADInstruments, Dunedin, New Zealand). Bilateral measures of arterial blood 
velocity and diameter were measured by a single experienced investigator 
(I.D.B.) at the ICA and VA using duplex Doppler ultrasound (Mindray M7, 
Shenzhen, GNG, China) with a 7.5 MHz linear array transducer and ultrasound 
gel, performed in brightness mode for the assessment of the diameter and the 
time-averaged mean blood flow velocity was acquired with the pulsed-wave 
mode. The sample volume was adjusted to capture the entire vessel lumen and 
the insonation angle was kept below 60°. Images were recorded and stored for 
offline analysis. 
5.3.2. Protocol 
A preliminary visit to the laboratory consisted on a medical screening and a 
maximal incremental exercise test on a cycle ergometer. A protocol starting with 
a warm-up period of 5 min at 100 W (young untrained), 150 W (young trained), 
50 W (old trained) and 20 W (old untrained) followed by 30 W increases per 
minute in young untrained and young and old trained individuals and 20 W 
increases per minute in old untrained individuals until exhaustion was used to 
determine VO2max and maximal workload. 
On the main study visit, participants were instrumented and then rested for 10 
min in a comfortable semi-supine position followed by bilateral ICA and VA 
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diameter and velocity measurements performed for the calculation of global 
cerebral blood flow. MAP, HR, PETCO2 and MCA Vmean were then recorded for 3 
min. After determination of basal PETCO2 levels, a hypercapnic test protocol 
was then conducted whereby CO2 from an external compressed gas cylinder 
was mixed and added to the inspired air (Altitrainer, SMTEC, Nyon, 
Switzerland) through the face mask to reach a stable plateau in PETCO2 at 1.5 
mmHg (step 1) and 5.5 mmHg (step 2) above baseline measurements for 120 s 
in each step. This protocol was chosen because it has been previously reported 
that maintenance of PETCO2 at 1.5 mmHg above baseline allows for a better 
control of PETCO2 and consequently reduces the variability in MCA Vmean (Harris 
et al., 2006). MAP, HR, PETCO2 and MCA Vmean were recorded throughout, and 
ICA diameter and velocity measurements made at each step. 
5.3.3. Data analysis 
Body mass index (BMI) was calculated dividing the participants’ weight by the 
square of the height. MAP was calculated using the formula: 
   
 
  
   
 
, where 
SBP is the systolic blood pressure and DBP is the diastolic blood pressure. 
Analysis of the ultrasound data was made offline using the recorded images by 
a blinded investigator. Arterial diameter was measured using NIH ImageJ 
software (Schneider et al., 2012) and blood flow velocity was measured by the 
machine software. Internal carotid artery measurements were performed ~1.5 
cm from the bifurcation of the common carotid artery. VA measurements were 
performed between the transverse process of the C3 vertebra and the 
subclavian artery. Mean systolic and diastolic diameters were averaged over at 
least 5 cardiac cycles to determine the mean artery diameter and the mean flow 
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velocity was obtained from the machine over 5 to 10 cardiac cycles. Blood flow 
in each artery was calculated as: 
    
             
 
 
 
                    
CVCi was calculated dividing the MCA Vmean by the MAP and ICA conductance 
was calculated dividing the ICA flow by the MAP. 
CVRCO2 was calculated as the change in ICA (flow) and MCA (mean velocity) 
per mmHg PETCO2 between the first +1.5 mmHg and the +5.5 mmHg PETCO2 
steps (Harris et al., 2006) as shown by the formulae: 
     
       
 or 
            
       
, 
where ∆PETCO2 is the absolute change in PETCO2, ∆Flow is the absolute 
change in ICA blood flow or MCA Vmean and %Flow change is the relative 
(percent) change in either ICA blood flow or MCA Vmean between steps. 
Due to insufficient image quality occasionally participants were omitted from 
aspects of the analysis and participant numbers are stated within the legend of 
each Table and Figure. 
5.3.4. Statistical analysis 
Values are reported as mean (95 % confidence interval) in text or SD in Tables 
and Figures. Two-way ANOVA with age (Young, Old) and training status 
(Trained, Untrained) as main factors was used, and the F-values are reported 
alongside the significance. Normality was assessed through Shapiro-Wilk test 
and non-normally distributed data underwent log10 transformation prior to 
statistical analysis. Effect sizes (d) were calculated as a quotient of the 
difference between means by the pooled SD. IBM SPSS Statistics 22 (IBM 
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Corp., Armonk, NY, USA) was used for analysis and statistical significance set 
at p < 0.05. 
  
93 
 
5.4. Results 
5.4.1. Participant characteristics 
The age difference between young and old participants was ≈ 42 years (F(1,31) 
= 454.5, p < 0.001), however neither the trained and untrained young 
participants, nor the trained and untrained old participants differed in age (Table 
5.1). BMI was higher in the old group (F(1,31) = 8.3, p = 0.007, d = 1.01), while 
MAP was not different between groups and resting HR tended to be lower in the 
trained individuals (F(1,31) = 4.0, p = 0.053, d = -0.76). PETCO2 was lower in the 
old (F(1,31) = 12.5, p = 0.001, d = -1.27), and as expected VO2max was higher 
in the trained (F(1,31) = 47.8, p < 0.001, d = 1.12) and young individuals 
(F(1,31) = 168.6, p < 0.001, d = 2.86). 
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Table 5.1. Participants’ characteristics 
      F and P value 
  Trained Untrained Age Training Interaction 
Age (years)         
Young 23 (4) 25 (5) F(1,31) = 
454.5 
P < 0.001 
F(1,31) = 0.8 
P = 0.371 
F(1,31) = 
0.1 
P = 0.824 
      
Old 65 (3) 67 (7) 
BMI (kg·m-2)         
Young 21.5 (1.5) 23.2 (1.9) F(1,31) = 
8.3 
P = 0.007 
F(1,31) = 1.6 
P = 0.214 
F(1,31) = 
0.8 
P = 0.383 
      
Old 24.5 (2.9) 24.8 (3.0) 
VO2 Max (mL·kg
-1·min-1)       
Young 65.0 (2.8) 50.3 (4.4) F(1,31) = 
168.6 
P < 0.001 
F(1,31) = 
47.8 
P < 0.001 
F(1,31) = 
0.0 
P = 0.867 
      
Old 40.4 (8.3) 30.5 (3.3) 
HR (bpm)           
Young 72 (14) 86 (19) F(1,31) = 
2.5 
P = 0.122 
F(1,31) = 4.1 
P = 0.053 
F(1,31) = 
0.3 
P = 0.586 
      
Old 66 (13) 74 (12) 
PETCO2 (mmHg)         
Young 36.5 (2.5) 36.1 (3.4) F(1,31) = 
12.5 
P = 0.001 
F(1,31) = 0.0 
P = 0.942 
F(1,31) = 
0.2 
P = 0.651 
      
Old 32.5 (3.4) 33.0 (2.0) 
MAP (mmHg)         
Young 89.5 (8.8) 91.6 (8.0) F(1,31) = 
0.0 
P = 0.911 
F(1,31) = 0.5 
P = 0.489 
F(1,31) = 
0.0 
P = 0.954 
      
Old 89.7 (8.2) 92.2 (12.8) 
BMI, body mass index; MAP, mean arterial pressure; HR, heart rate; PETCO2, partial pressure of 
arterial carbon dioxide; VO2max, maximal oxygen consumption. Young untrained n = 10, young 
trained n = 10, old untrained n = 8, old trained n = 7. Values are reported as mean (SD). 
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5.4.2. Resting cerebral blood flow 
Bilateral ICA and VA blood flow, and MCA Vmean, in young and old, trained and 
untrained groups are shown in Figure 5.1. Bilateral ICA blood flow was ≈ 31% 
higher in trained when compared to untrained individuals (F(1,28) = 5.8, p = 
0.022; d = 0.85). However, no significant main effect of age (F(1,28) = 0.3, p = 
0.619, d = 0.28) or interaction between training status and age (F(1,28) = 0.9, p 
= 0.342) was observed in bilateral ICA flow. No effect of age (F(1,31) = 1.2, p = 
0.282, d = 0.39), training status (F(1,31) = 0.9, p = 0.344, d = -0.38) or 
interaction between age and training status (F(1,31) = 0.4, p = 0.551) was 
observed on the bilateral VA blood flow. However, MCA Vmean was lower in old 
individuals (Young: 59.5 (55.0 to 64.1) cm·s-1 and Old: 43.6 (38.4 to 48.9) cm·s-
1, F(1,31) = 21.5, p < 0.001, d = -1.67), with no significant effect of training 
status (F(1,31) = 0.8, p = 0.377, d = 0.29) or interaction between age and 
training status (F(1,31) = 0.0, p = 0.920) observed.  
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Figure 5.1. Bilateral internal carotid artery (ICA) blood flow (A), vertebral artery (VA) blood 
flow (B) and mean middle cerebral artery blood flow velocity (MCA Vmean, C) in young and 
old, trained and untrained subjects. 
Young untrained n = 10, young trained n = 10, old untrained n = 5 (A) or 8 (B and C), old 
trained n = 7. Filled circles show untrained and open circles show trained individuals. The 
small circles are individual values, while larger circles denote the mean for that fitness 
group. 
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5.4.3. Cerebral vascular reactivity 
Table 5.2 shows changes in MAP, PETCO2, blood flow, arterial diameter and 
blood velocity at the right ICA during hypercapnia in young and old, trained and 
untrained groups. All groups exhibited similar increases in PETCO2 (≈ 4 mmHg) 
and MAP (≈ 4 mmHg) with hypercapnia. Figure 5.2 shows the ICA and MCA 
CVRCO2 in young and old, trained and untrained individuals. No main effect of 
age or training status was noted for the absolute ICA CVRCO2 (Figure 5.2 A). 
However, one old untrained individual was classified as an outlier (i.e., an 
extreme). If removed the main effects of age (F(1,29) = 1.6, p = 0.209; d = 0.40) 
and fitness (F(1,29) = 2.4, p = 0.133; d = 0.36) remain, but a significant 
interaction is observed (F(1,29) = 4.6, p = 0.041). Post-hoc analysis using the 
Bonferroni adjustment shows a significant difference between old trained vs old 
untrained (t = 2.365, p = 0.025, d = 1.24) and between old trained and young 
trained individuals (t = 2.368, p = 0.025, d = 1.01). Relative ICA CVRCO2 was not 
statistically different in the young and old, trained and untrained groups (Figure 
5.2 C), but there was a tendency for a higher relative ICA CVRCO2 in old when 
compared to young individuals (F(1,29) = 3.0, p = 0.094, d = 0.77), being 
particularly marked in old trained individuals (d = 1.22). No main effects of age 
or training status were noted in either the ICA flow, diameter or Vmean responses 
to hypercapnia, when expressed as either an absolute or percentage change. 
Although a tendency for a greater percentage ICA blood flow increase in old 
individuals was noted (F(1,29) = 3.2, p = 0.083, d = 0.63). The MCA CVRCO2 
was not different in the young and old, trained and untrained groups (Figure 5.2 
B and D). 
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Figure 5.2. Cerebral vascular reactivity to carbon dioxide (CVRCO2) at the internal carotid 
artery (ICA, A and C) and middle cerebral artery (MCA, B and D) in young and old, trained 
and untrained subjects. 
Young untrained n = 10, young trained n = 9 (A and C) or n = 10 (B and D), old untrained n 
= 8, old trained n = 6 (A and C) or n = 7 (B and D). Filled circles show untrained and open 
circles show trained individuals. The small circles are individual values, while larger circles 
denote the mean for that fitness group. † indicates the outlier (the data presented in the 
figure includes the outlier) 
† 
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Table 5.2. Changes in PETCO2, blood pressure, arterial diameter, blood flow velocity and blood flow at the right ICA in response to hypercapnia 
      F and P value 
  Trained Untrained Age Training Interaction 
Δ PETCO2  (mmHg)         
Young 4.1 (1.4) 4.2 (0.7) F(1,29) = 0.1 
P = 0.823 
F(1,29) = 0.5 
P = 0.499 
F(1,29) = 0.2 
P = 0.655 Old 3.9 (1.3) 4.3 (1.2) 
Δ MAP  (mmHg)         
Young 3.4 (4.8) 2.6 (3.6) F(1,29) = 1.5 
P = 0.230 
F(1,29) = 0.0 
P = 0.837 
F(1,29) = 0.7 
P = 0.413 Old 3.9 (2.8) 5.2 (2.7) 
Δ ICA blood flow (%)         
Young 15.0 (14.2) 19.3 (10.1) F(1,29) = 3.0 
P = 0.083 
F(1,29) = 0.0 
P = 0.854 
F(1,29) = 1.0 
P = 0.335 Old 29.8 (13.2) 23.6 (21.2) 
Δ ICA Vmean (%)         
Young 6.3 (14.1) 6.8 (11.0) F(1,29) = 2.3 
P = 0.142 
F(1,29) = 0.0 
P = 0.839 
F(1,29) = 0.0 
P = 0.921 Old 13.2 (11.0) 14.7 (18.5) 
Baseline ICA diameter (mm)         
Young 5.2 (0.6) 4.7 (0.9) F(1,29) = 0.1 
P = 0.785 
F(1,29) = 0.3 
P = 0.571 
F(1,29) = 1.9 
P = 0.180 Old 4.9 (0.4) 5.1 (0.6) 
Δ ICA diameter (%)         
Young 2.7 (1.9) 5.8 (3.5) F(1,29) = 0.7 
P = 0.419 
F(1,29) = 0.0 
P = 0.914 
F(1,29) = 4.0 
P = 0.052 Old 7.3 (7.5) 3.9 (5.3) 
ICA, internal carotid artery; Vmean, mean blood velocity; MAP, mean arterial pressure. Young untrained n = 10, young trained n = 9, old untrained n = 8, 
old trained n = 6. Values are reported as mean (SD). 
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Table 5.2 (continued). Changes in PETCO2, blood pressure, arterial diameter, blood flow velocity and blood flow at the right ICA in response to 
hypercapnia 
      F and P value 
  Trained Untrained Age Training Interaction 
Δ ICA blood flow (mL·min-1)       
Young 73.5 (86.6) 77.3 (47.6) F(1,29) = 0.9 
P = 0.347 
F(1,29) = 0.1 
P = 0.709 
F(1,29) = 0.3 
P = 0.614 Old 114.8 (72.2) 89.8 (104.4) 
Δ ICA Vmean (cm·s
-1)         
Young 1.69 (2.87) 1.40 (2.06) F(1,29) = 0.3 
P = 0.592 
F(1,29) = 0.0 
P = 0.857 
F(1,29) = 0.0 
P = 0.879 Old 2.02 (1.81) 2.00 (2.68) 
Δ ICA diameter  (mm)         
Young 0.15 (0.11) 0.28 (0.15) F(1,29) = 0.9 
P = 0.349 
F(1,29) = 0.1 
P = 0.783 
F(1,29) = 3.5 
P = 0.072 Old 0.39 (0.42) 0.21 (0.29) 
ICA, internal carotid artery; Vmean, mean blood velocity; MAP, mean arterial pressure. Young untrained n = 10, young trained n = 9, old untrained n = 8, 
old trained n = 6. Values are reported as mean (SD). 
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5.5. Discussion 
This study sought to determine if cardiorespiratory fitness enhances cerebral 
blood flow and CVRCO2 in healthy elderly individuals. The main findings of this 
study were that a higher cardiorespiratory fitness was associated with a ≈ 31% 
greater ICA flow whereas VA flow was not influenced by age or 
cardiorespiratory fitness. In addition, MCA Vmean was reduced with age, but did 
not appear to be affected by cardiorespiratory fitness. Finally, neither age nor 
cardiorespiratory fitness significantly influenced MCA CVRCO2, while there was 
a non-significant tendency for ICA CVRCO2 to be enhanced in old trained 
individuals.  
Reduced cerebral blood flow is a risk factor for cerebral vascular and 
neurodegenerative diseases, and regional cerebral hypoperfusion has been 
associated with cognitive decline and Alzheimer’s disease (Thome et al., 1996). 
In key regions of the brain such as the hippocampus, aerobic exercise training 
can improve perfusion which is related to the hippocampal volume, indicative of 
a preserved vascular function in elderly individuals (Maass et al., 2014). It was 
found that cardiorespiratory fitness was associated with a greater global 
cerebral blood flow, in young and older individuals when compared to their 
untrained age-matched counterparts. This finding supports the concept that 
maintaining a high cardiorespiratory capacity through life reduces the risk of 
cognitive decline and other neurodegenerative diseases (Erickson et al., 2011).  
Although ICA blood flow was higher in trained participants when compared to 
untrained individuals, VA flow was not different. The irrigation of most of the 
cerebral cortex and deep forebrain structures originates from the ICA, whereas 
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the merged left and right VAs form the basilar artery, which is responsible for 
the blood supply to the cerebellum, pons and provides branches for some 
forebrain structures. Differences in the regulation of blood flow within the 
posterior and anterior circulations have been identified. For example, the carotid 
arteries possess a greater supply of autonomic nerve fibres than the vertebral 
arteries (Edvinsson et al., 1976), while resting CO2 responsiveness is reportedly 
lower in the posterior inferior cerebellar artery than the contralateral middle 
cerebral artery (Reinhard et al., 2008). ICA and VA blood flow responses to 
physiological stressors also differ. During head-up tilt the blood flow in the ICA 
is reduced but preserved in the VA (Sato et al., 2012a). In addition, an acute 
bout of exercise promotes a blood flow increase in both ICA and VA, although 
at exercise intensities higher than 60%, the ICA flow returns to baseline and VA 
flow increases to reach a maximum at 100% VO2max (Sato et al., 2011). The 
findings from this chapter support the existence of a regional specificity in the 
cerebral blood flow adaptations to exercise training with a favouring of the areas 
of the brain that are responsible for the planning and execution of movement 
(Secher et al., 2008). However, whether the resting cerebral blood flow 
adaptations observed in this study influence the regional cerebral blood flow 
responses to an acute bout of exercise has not been investigated. 
In rats, it has been shown that physical activity in early life can have long lasting 
positive effects in the brain such as increased neuron maturation and survival 
(Merkley et al., 2014), and aerobic exercise training also increases 
angiogenesis and recruitment of endothelial progenitor cells after MCA 
occlusion (Gertz et al., 2006). Accordingly, the reasons for greater cerebral 
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blood flow observed in aerobically fit individuals might range from increased 
microvasculogenesis and improved endothelial function to enhanced cardiac 
function (Bolduc et al., 2013). Additional studies are required to translate the 
mechanistic findings from animal models to humans. Cardiac output has been 
shown to independently influence cerebral perfusion in humans (Ogoh et al., 
2005), but as resting cardiac output was not measured it is unclear whether it 
explains the greater cerebral blood flow observed in aerobically fit individuals. 
However, since resting cardiac output is reportedly unchanged with training, 
largely because an increase in stroke volume is counterbalanced by a decrease 
in HR (Scheuer & Tipton, 1977), it is likely that this would not explain the 
training-related cerebral blood flow differences observed. 
When assessed by transcranial Doppler ultrasonography no effect of 
cardiorespiratory fitness on cerebral perfusion was detected. In contrast, in a 
study of 307 individuals aged between 18 and 79 years, higher MCA Vmean was 
observed in trained individuals (Ainslie et al., 2008). The discrepancy between 
previous studies may relate to the relatively small sample size of this study. 
Transcranial Doppler is a technique which can assess blood velocity with a high 
temporal resolution, but is reported not to correlate well with [133Xe] determined 
global cerebral blood flow at rest in some (Bishop et al., 1986; Hartmann et al., 
1991) but not all studies (Sorteberg et al., 1989; Dahl et al., 1992), and the 
validity of transcranial Doppler as a surrogate marker of cerebral blood flow is 
subject of debate (Ainslie & Hoiland, 2014). On the other hand, duplex Doppler 
ultrasonography of the extracranial arteries correlates well with other techniques 
of global brain blood flow assessment (Dorfler et al., 2000), although duplex 
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ultrasound validation against a gold-standard technique is still lacking. The 
findings of studies investigating the impact of cardiorespiratory fitness on 
CVRCO2 are conflicting. Zhu et al (2013) reported similar MCA CVRCO2  in 
sedentary elderly individuals and masters athletes, suggesting that life-long 
exercise training has a minimal impact on cerebral vasomotor regulation. 
Whereas, using magnetic resonance imaging, Thomas et al (2013) showed that 
CVRCO2 was in fact reduced in masters athletes when compared to sedentary 
elderly participants. In contrast, Barnes et al (2013) and Bailey et al (2013b) 
reported that MCA CVRCO2 is better in those elderly individuals with higher 
aerobic capacity. Neither age nor cardiorespiratory fitness influenced MCA 
CVRCO2 in this study. In addition, no significant main effect of age or training 
status was noted for the absolute ICA CVRCO2. However, upon close inspection 
of the data one old untrained individual was deemed to be an outlier (i.e., an 
extreme). With this individual removed a significant interaction between age and 
training was observed, with post hoc analysis a significantly greater ICA 
CVRCO2 in old trained group compared to the old untrained and young trained 
groups was observed. As the outlier does not appear to have resulted from an 
artefact and the value is genuine, a consideration of the data both with and 
without them included was provided. Tendencies for a higher relative ICA 
CVRCO2 and ICA blood flow during the hypercapnic challenge were noted in old 
trained individuals. Taken together these data suggest that the potential for an 
enhanced CVRCO2 of the ICA cannot be completely discounted.  
The effect of normal and healthy ageing on cerebral blood flow and its 
regulation is still debated. Although many studies show that cerebral perfusion 
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is reduced with age (Leenders et al., 1990; Ainslie et al., 2008), there is also 
evidence that global cerebral blood flow may not be reduced with age (Meltzer 
et al., 2000; van Es et al., 2010). It was observed in this study that cerebral 
blood flow was not influenced by age when assessed by Doppler ultrasound at 
the ICA and VA, but cerebral blood velocity assessed by transcranial Doppler 
ultrasonography at the MCA was reduced in older individuals. These 
unexpected findings may be explained by the increase in diameter of cerebral 
arteries during ageing (Ozdogmus et al., 2008) and discrepancies between 
transcranial Doppler with other measurement techniques such as the use of 
[133Xe] for resting absolute cerebral perfusion assessment (Bishop et al., 1986; 
Hartmann et al., 1991). However, only longitudinal studies with a long follow-up 
period using multiple methodologies could reduce the uncertainty over this age-
related cerebral blood flow decline. 
Duplex ultrasound has been extensively used clinically and for research 
purposes, and was shown to have a good correlation when compared to phase-
contrast magnetic resonance imaging technique (Oktar et al., 2006). However, 
no account was made for cerebral volume and thus relative blood flow to 
cerebral mass. Post-hoc analysis showed that the sample size of this study was 
adequate to permit identification of a minimal detectable difference in bilateral 
ICA flow of 200 mL·min-1 based on a two-way ANOVA model with an interaction 
term, at 80% power and 5% alpha. However, larger samples may be needed to 
assess the influence of cardiorespiratory fitness on the CVRCO2. Furthermore, 
the focus of this study on a small sample of healthy individuals restricts the 
possibility of extrapolation of these results to a wider population including 
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people with diseases. Finally, the absence of a gold-standard protocol to assess 
the CVRCO2 greatly limits the comparison between studies. 
 
Perspective 
Age is one of the most important non-modifiable risk factors for brain diseases 
such as dementia and stroke (Sacco et al., 1997; Lindsay et al., 2002). 
Alterations in brain structure and function occur even in ‘healthy ageing’ (Scahill 
et al., 2003; Burgmans et al., 2011). Regular physical activity has a number of 
beneficial effects on the brain, but the underlying mechanisms are incompletely 
understood. In the present study it was observed that aerobically trained 
individuals have higher bilateral ICA flow. Further studies are required to assess 
the impact of higher cerebral blood flow and cardiorespiratory fitness in healthy 
ageing and neurodegenerative conditions such as Alzheimer’s and Parkinson’s 
disease. 
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CHAPTER 6: CEREBRAL BLOOD FLOW REGULATION IN 
ATRIAL FIBRILLATION 
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6.1. Introduction 
AF is the most common sustained cardiac rhythm abnormality, affecting ≈2 % of 
the general population in Europe (Zoni-Berisso et al., 2014). It is strongly 
associated with advanced age, with an incidence of 1.1/1000 person-years in 
people aged 55-59 rising to 20.7/1000 person-years in the 80-84 years group 
(Heeringa et al., 2006). Although AF is known to be a major risk factor for stroke 
and dementia even without clinical history of cerebral vascular disease (Ott et 
al., 1997), the mechanisms underlying the increased risk of cerebral 
thromboembolism and cognitive impairment are not fully understood. 
The irregular blood flow through the heart in people with AF leads to left atrium 
stasis, and is associated with structural heart disease, endocardial dysfunction, 
and enhanced blood haemostatic properties. These factors contribute to a 
prothrombotic state in the heart that may result in cerebral thromboembolism by 
affecting all the components of the Virchow’s triad (Watson et al., 2009). The 
consequences of stroke in patients with AF are more severe when compared to 
patients without AF.  It has been reported that AF patients have a higher 30-day 
mortality and poorer functional status as indicated by the Barthel scale when 
compared to sinus rhythm stroke patients (Lin et al., 1996). Even in the absence 
of previous stroke, patients with AF have reduced hippocampal volume and 
perform worse in memory, learning, attention and execution tasks when 
compared to individuals without AF from the same community (Knecht et al., 
2008). The mechanisms promoting these poorer outcomes in people with AF 
have not been fully elucidated. An impaired cerebral vasomotor regulation is 
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one potential factor which may contribute to the worse stroke outcomes as well 
as poorer cognitive performance. 
A reduced resting hemispheric cerebral blood flow of ≈13% has been 
documented in individuals with AF aged between 51 and 65 years, with no 
signs of heart failure or cerebral vascular disease (Lavy et al., 1980). The 
authors suggested that low cardiac output and/or impaired cerebral 
autoregulation could be responsible for this cerebral blood flow reduction in AF 
patients. Poor cerebral blood flow in AF may lead to vasodilatation of cerebral 
arterioles which may impair cerebral autoregulation by reducing vasodilatory 
reserve (Aaslid et al., 1989). However, another study has shown that cerebral 
perfusion improved with cardioversion even without significant changes in 
cardiac output (Petersen et al., 1989b). 
Endothelium-derived NO is an important local regulator of cerebral blood flow 
(Hainsworth et al., 2015), and NO-dependent cerebral vessels dilatation is 
reportedly impaired in patients with hypertension and diabetes (Lavi et al., 
2006). Systemic endothelial function has been shown to be impaired in patients 
with AF when compared with healthy controls (Conway et al., 2003; Freestone 
et al., 2008). The concentration of plasma von Willebrand factor, a marker of 
endothelial damage that has been shown to be predictive of cerebral vascular 
events, is elevated in AF (Conway et al., 2003). Furthermore, an impaired flow-
mediated dilatation of the brachial artery has also been identified in patients 
with chronic AF, indicative of endothelial dysfunction and diminished NO 
signalling (Freestone et al., 2008). 
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Although NO and the endothelium are known to modulate cerebral 
haemodynamics, it is still largely unknown whether the cerebral vascular 
function is chronically impaired in patients with AF. The purpose of this study 
was to determine whether cerebral vascular function is impaired in AF. To do 
that, CVRCO2 and cerebral autoregulation were assessed in patients with AF, 
hypertension and healthy volunteers. Patients with hypertension were used as a 
‘disease control’ group as AF is commonly associated with other cardiovascular 
risk factors and comorbidities. It was hypothesised that patients with AF would 
have a lower CVRCO2 and diminished cerebral autoregulation when compared 
to healthy age-matched controls and patients with hypertension (i.e. disease 
control). 
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6.2. Methods 
6.2.1. Ethics 
All procedures performed were approved by the National Research Ethics 
Service Committee West Midlands - The Black Country (13/WM/0210) and 
conformed to the Declaration of Helsinki. Prospective participants were given an 
information sheet and all procedures were verbally explained in detail. After 
having the opportunity to ask questions and clarification over each procedure 
performed, written informed consent was obtained from willing volunteers. 
6.2.2. Participants 
Fourteen AF patients, 8 hypertensive patients and 10 healthy control 
participants were recruited. Patients with AF and primary hypertension were 
recruited from dedicated clinics at the City Hospital, Birmingham while healthy 
age-matched controls were recruited from the surrounding communities. Seven 
of the fourteen AF patients also had hypertension and 5 were fibrillating during 
the examination. Patients with left ventricular dysfunction, valvular heart 
disease, previous myocardial infarction, respiratory, connective tissue, 
inflammatory or neurological diseases, malignancy or uncontrolled thyroid 
disorders upon screening were not recruited to participate in this study. Healthy 
participants were free from disease and not taking any prescription or over-the-
counter medication. If a healthy participant was found to have high blood 
pressure (systolic >140 mmHg or diastolic >90 mmHg) during the test, they 
were recommended to have an appointment with the GP. Two healthy 
participants had systolic blood pressure readings higher than 140 mmHg and 
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were referred this way, but in a follow-up contact they were found to have 
normal blood pressure. 
6.2.3. Measurements 
Cognitive function was assessed prior to the cardiovascular assessment using 
the MoCA. Beat-by-beat blood pressure was continuously obtained from the 
third or fourth finger from the left hand (Finometer MIDI, Finapres Medical 
Systems, Amsterdam, The Netherlands) and was verified by resting brachial 
arterial pressure (M2, Omron, Kyoto, Japan). MCA Vmean was also recorded 
continuously using transcranial Doppler (Doppler BoxX, DWL, Sipplingen, 
Germany) with the technique described in section 3.2.2. HR was monitored 
through lead II ECG (BioAmp, ADInstruments, Dunedin, New Zealand). Tidal 
volume and minute ventilation were measured using an oronasal mask 
connected to a heated pneumotach (Hans Rudolph, Kansas City, KS, USA). 
The mask was also connected to a capnograph which continuously sampled the 
gas and provided PETCO2 measures (RespSense, Nonin medical, Plymouth, 
MN, USA). Analogue signals were digitized at 1 kHz (Powerlab, ADInstruments, 
Dunedin, New Zealand) and recorded using a multi-channel data acquisition 
software (Labchart 7, ADInstruments, Dunedin, New Zealand). 
6.2.4. Protocol 
Patients were asked to refrain from taking any medication (excluding 
anticoagulants) on the study day. On the study visit, a blood sample was taken 
and analysed for full blood count, glucose, lipids, kidney and liver function. 
Cognition was assessed using the MoCA. Then, participants were asked to lie 
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comfortably on a bed where the vascular assessment took place. Firstly, a ten-
minute baseline was acquired while participants were breathing room air. 
CVRCO2 
CVRCO2 was assessed by increasing or decreasing the inspired fraction of CO2 
through a two-way valve connected to either Douglas bags filled with enriched 
CO2 or room air. Participants were given 4 % CO2 (≈21 % O2) for four minutes, 
followed by 7 % CO2 (≈21 % O2) for another four minutes, then switched back to 
room air. After PETCO2, MCA Vmean, haemodynamic and respiratory variables 
returned to baseline, participants were asked to increase the respiratory depth 
and rate in order to achieve the same magnitude but opposite change in 
PETCO2 during the hypercapnic states, with each step lasting 2 minutes. 
Cerebral autoregulation 
Cerebral autoregulation was assessed by asking the participants to stand after 
sitting comfortably in a chair for a period of 2 minutes. This manoeuvre 
generates a drop in MAP that is followed by a fall in MCA Vmean and the 
magnitude of adaptations is an index of cerebral autoregulation (section 3.3.2, 
Figure 3.3). Cerebral autoregulation was also assessed in the frequency 
domain by the means of TFA, as described in section 3.3.2. Gain, phase and 
coherence were derived from the auto- and cross-spectrum between MAP and 
MCA Vmean. As low coherence values may prevent the analysis of gain and 
phase, TFA was performed using spontaneous fluctuations of the MAP during 
baseline as well as during a period of five minutes of squat-to-stand manoeuvre 
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at 0.1 Hz. The repeated squat-to-stand aims to drive oscillations in MAP at the 
desired frequency range in order to improve TFA coherence. 
6.2.5. Data analysis 
BMI was calculated dividing the participants’ weight by the square of the height. 
MAP was calculated as the mean blood pressure throughout each cardiac cycle 
by the acquisition software. CVCi was calculated as MCA Vmean divided by 
MAP. Baseline was calculated as the mean of the whole 10-minute period, and 
mean values were acquired over the last minute of each hypercapnic or 
hypocapnic step. Hypercapnic CVRCO2 was calculated as the slope of the MCA 
Vmean change between the two hypercapnic steps, while the hypocapnic CVRCO2 
was calculated as the slope between the two hypocapnic steps (Peebles et al., 
2007). Sit-to-stand MAP, MCA Vmean and PETCO2 averages were obtained over 
the 20 s before standing for the baseline and over 5 cardiac cycles around the 
nadir of MAP after standing (den Abeelen et al., 2014). TFA was performed with 
spontaneous fluctuation of MAP and during the repeated squat-to-stand 
manoeuvre as described in section 3.2.2 and following recommendations of 
current guidelines (Claassen et al., 2016). 
6.2.6. Statistical analysis 
Normality was assessed by the Shapiro-Wilk test. Normally distributed data 
were analysed using one-way ANOVA, while non-normally distributed data were 
analysed using Kruskal-Wallis H tests. Given that the aim of the study was to 
determine whether cerebral vascular function is impaired in AF, one-way 
ANOVA was independently used to compare hypercapnic and hypocapnic 
CVRCO2 in patients with AF, hypertension and healthy volunteers. Therefore, 
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interactions between group and CO2 stimulus (i.e. hypocapnia and hypercapnia) 
were not considered. Significance was set at p < 0.05. Normally distributed data 
are presented as mean (SD) while non-normally distributed data are presented 
as median [intrequartile range]. Multiple pairwise comparisons using the Dunn’s 
method were performed when a significant difference between groups was 
found by the Kruskal-Wallis H test, and the Bonferroni method if a significant 
difference was found on the ANOVA. Effect sizes (d) were calculated as the 
difference of means divided by the pooled SD. Statistical analysis was 
performed using Sigmaplot 12.5 (Systat Software Inc, London, UK). 
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6.3. Results 
Participant characteristics and baseline data are presented on Table 6.1. There 
were no significant differences in age, BMI, HR, blood pressure parameters or 
cognition between the AF, hypertension and healthy control groups.  
As shown in Figure 6.1, MCA Vmean tended to be higher in controls when 
compared to AF (d = 0.83) and hypertensive patients (d = 0.82), although they 
were not significantly different (p = 0.127). PETCO2 tended to be higher in 
participants with hypertension, although this finding did not reach statistical 
significance (p = 0.064). No differences in CVCi or minute ventilation were 
observed between groups. 
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Table 6.1. Participants characteristics and baseline data 
  Control (n=10) AF (n=14) HT (n=8) p value 
Age (yr) 67.5 [66-70]  66.5 [59.5-69.25]   65.5 [63.5-71.5] 0.404 
Sex (n female) 4 3 4 - 
BMI (kg·m-2) 24.0 (3.1)  26.1 (4.7)  27.7 (4.5)  0.185 
MoCA (score) 28.5 [26.75-29.25] 27 [25-28] 28 [26.25-30] 0.486 
Hypertension (n) - 7 8 - 
HR (bpm) 58 [56-61] 60 [54-77] 57 [54-63] 0.589 
SBP (mmHg) 143 (19) 134 (20) 138 (15) 0.525 
DBP (mmHg) 78 (10) 76 (11) 78 (10) 0.800 
MAP (mmHg) 100 (13) 95 (12) 98 (11) 0.666 
Medications (n)       
 β-blockers - 6 0 - 
 ACEi - 3 1 - 
 ARB - 1 1 - 
 Ca
++
 channel blockers - 3 7 - 
 Diuretics - 2 4 - 
 OACs - 11 0 - 
Values are displayed as mean (SD) when normally distributed or median [interquartile range] (non-normally 
distributed). BMI, body mass index; MoCA, Montreal cognitive assessment; HR, heart rate; SBP, systolic 
blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; ACEi, angiotensin-converting 
enzyme inhibitors; ARB, angiotensin receptor blockers; OACs, oral anticoagulants. *p < 0.05 vs control. 
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Figure 6.1. Resting cerebral vascular and respiratory characteristics in healthy controls, 
patients with atrial fibrillation (AF) and hypertension (HT). 
MCA Vmean, middle cerebral artery blood velocity; PETCO2, partial pressure of end-tidal CO2; 
CVCi, cerebral vascular conductance index; AF, atrial fibrillation; HT, hypertension 
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CVRCO2 assessment 
Figure 6.2 shows cerebral perfusion responses to the hypocapnic and 
hypercapnic steps in the AF, hypertension and control groups. The hypercapnic 
CVRCO2 slope was lower in AF patients when compared to healthy controls (d = 
1.29), but not significantly different from hypertensive participants (d = 0.51) 
(Figure 6.3 A). However, the hypocapnic CVRCO2 slope was not significantly 
different between groups (Figure 6.3 B). One outlier (i.e. > 3rd quartile + 3 * 
interquartile range) was found in the AF group for the hypercapnic CVRCO2 
slope. As this value appeared not to be attributable to a methodological error 
with data collection or analysis, this individual was included in the statistical 
analysis. Haemodynamic and ventilatory responses to the hypercapnic and 
hypocapnic tests were not significantly different between groups at each step 
(Table 6.2). 
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Figure 6.2. Graphical representation of the cerebral and systemic haemodynamic and 
ventilatory responses to the hypocapnic and hypercapnic challenges. 
MCA Vmean, middle cerebral artery blood velocity; PETCO2, partial pressure of end-tidal CO2; 
CVCi, cerebral vascular conductance index; MAP, mean arterial pressure. 
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Figure 6.3. Hypercapnic and hypocapnic cerebral vascular reactivity to CO2 (CVRCO2) 
slopes in healthy controls, patients with atrial fibrillation (AF) and hypertension (HT). 
CVRCO2, cerebral vascular reactivity to CO2; AF, atrial fibrillation; HT, hypertension. The left 
column of each group represents median and interquartile range (A) or mean and standard 
deviation (B), while the right column of each group displays the individual values. *p < 0.05 
vs Control. The dashed line in Panel B indicates the zero, with values below this line 
denoting an increase in MCA Vmean between the two steps of hypocapnia. 
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Table 6.2. Changes in haemodynamic and respiratory parameters during the hypercapnic and hypocapnic challenges 
  Control AF HT p value 
Hypercapnic     
∆MAP (mmHg) 8.8 [4.4, 17.2] 9.6 [3.9, 18.9] 12.2 [7.1, 15.7] 0.686 
∆HR (bpm) 6.1 (4.6)  5.3 (4.8)  8.0 (5.4)  0.495 
∆PETCO2 (mmHg) 7.0 (3.8) 7.7 (4.5) 7.0 (1.9) 0.871 
∆VE (L·min
-1) 5.3 (3.8) 8.3 (6.9) 8.1 (3.0) 0.394 
Hypocapnic     
∆MAP (mmHg) 1.6 (3.0) -1.5 (3.7) 0.1 (4.7) 0.184 
∆HR (bpm) 4.2 (3.4) 3.3 (4.2) 1.2 (2.5) 0.279 
∆PETCO2 (mmHg) -5.1 (2.1) -4.9 (2.5) -5.8 (1.5) 0.685 
∆VE (L·min
-1) 5.5 (2.9) 5.7 (4.1) 3.7 (4.0) 0.490 
Values are displayed as mean (SD) when normally distributed or median [interquartile range] (non-normally distributed). MAP, mean arterial pressure; 
HR, heart rate; PETCO2, partial pressure of end-tidal CO2; VE, minute ventilation. *p < 0.05 vs control. 
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Cerebral autoregulation 
As presented in Table 6.3 and Figure 6.4, there were no significant differences 
in changes in MCA Vmean, MAP, CVCi or PETCO2 evoked by a single sit-to-stand 
manoeuvre between groups. 
 
When assessed via TFA, the baseline MAP power in the very low frequency 
range and MCA Vmean power in the low frequency range were found to be lower 
in the hypertensive when compared to the control group (Table 6.4). Similarly, 
AF patients also had a significantly lower MAP power in the very low frequency 
range. Hypertensive patients had a lower coherence at the very low and low 
frequency range when compared to controls. Gain and phase in the frequency 
ranges studied were not different between groups. When the participants 
performed the repeated squat-to-stand manoeuvre, there were no significant 
differences in MAP or MCA Vmean power, gain, phase or coherence between 
Figure 6.4. Middle cerebral artery blood velocity responses to a single sit-to-stand 
manoeuvre in healthy controls, patients with atrial fibrillation and hypertension. 
MCA Vmean, middle cerebral artery mean blood velocity. *p < 0.05 vs Control. 
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groups in the very low or low frequency range. MAP power in the high 
frequency range was found to be lower in the hypertensive when compared to 
the control group (Table 6.5). One AF and one HT participants were excluded 
from this analysis due to participants’ time constraint on the testing day. 
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Table 6.3. Changes in haemodynamic, respiratory and cerebral vascular parameters during the 
single sit-to-stand manoeuvre 
  Control AF HT p value 
∆MCA Vmean 
(cm·s-1) 
-9.2 (9.5) -6.5 (5.7) -2.5 (3.9) 0.161 
∆MAP 
(mmHg) 
-18.9 (9.9) -16.7 (9.2) -18.3 (6.1) 0.834 
∆CVCi (cm·s-
1
·mmHg-1) 
-0.11 
[-0.15, -0.01] 
-0.07 
[-0.14, 0.04] 
-0.15 
[-0.24, -0.03] 
0.328 
∆PETCO2 
(mmHg) 
-0.6 [-1.0, 0.0] -0.5 [-2.3, 0.6] -0.4 [-1.5, 0.1] 0.929 
Values are displayed as the change (∆) in the means (SD) when normally distributed or median 
[interquartile range] (non-normally distributed). MCA Vmean, middle cerebral artery mean blood 
velocity; MAP, mean arterial pressure; CVCi, cerebral vascular conductance index; PETCO2, 
partial pressure of end-tidal CO2. *p < 0.05 vs control. 
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Table 6.4. Baseline dynamic cerebral autoregulation as quantified by transfer function analysis using signals of MAP and MCA Vmean  
 
Control AF HT p value 
VLF (0.02–0.07 Hz) 
MAP power (mmHg2) 8.5 [6.9, 11.3] 4.4 [1.9, 6.7]* 2.6 [1.1, 4.9]* 0.003 
MCA Vmean power (cm
2·s-2) 3.8 [2.4, 6.2] 1.7 [1.0, 3.0] 3.0 [0.6, 4.5] 0.077 
Coherence 0.68 [0.47, 0.76] 0.49 [0.26, 0.66] 0.32 [0.28, 0.39]* 0.006 
Gain (cm·s-1·mmHg-1) 0.59 (0.21) 0.60 (0.28) 0.71 (0.31) 0.611 
Gain (%·mmHg-1) 0.89 (0.23) 1.08 (0.24) 1.22 (0.42) 0.079 
Phase (radians) 55.8 [37.7, 74.2] 66.6 [41.3, 93.5] 32.0 [29.0, 56.2] 0.123 
LF (0.07–0.20 Hz) 
MAP power (mmHg2) 4.22 [2.42, 6.91] 3.83 [1.83, 9.97] 2.18 [1.20, 3.26] 0.106 
MCA Vmean power (cm
2·s-2) 3.85 (2.27) 2.92 (1.61) 1.60 (0.94)* 0.035 
Coherence 0.87 [0.75, 0.89] 0.78 [0.67, 0.88] 0.69 [0.64, 0.78]* 0.046 
Gain (cm·s-1·mmHg-1) 0.86 (0.22) 0.79 (0.30) 0.76 (0.20) 0.664 
Gain (%·mmHg-1) 1.41 [1.10, 1.52] 1.47 [1.21, 1.63] 1.40 [1.27, 1.60] 0.586 
Phase (radians) 35.4 (12.0) 30.3 (11.9) 31.4 (14.6) 0.616 
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Table 6.4 (continued). Baseline dynamic cerebral autoregulation as quantified by transfer function analysis using signals of MAP and MCA Vmean  
 
Control AF HT p value 
HF (0.20–0.50 Hz) 
MAP power (mmHg2) 1.02 [0.52, 1.85] 2.61 [0.35, 4.75] 0.52 [0.29, 1.03] 0.076 
MCA Vmean power (cm
2·s-2) 0.93 [0.65, 1.53] 1.66 [0.34, 4.66] 0.45 [0.21, 0.83] 0.108 
Coherence 0.87 [0.81, 0.91] 0.88 [0.70, 0.94] 0.65 [0.42, 0.89] 0.174 
Gain (cm·s-1·mmHg-1) 0.91 (0.14) 0.81 (0.25) 0.81 (0.27) 0.531 
Gain (%·mmHg-1) 1.42 (0.34) 1.50 (0.25) 1.48 (0.26) 0.775 
Phase (radians) -0.21 (5.24) 0.52 (4.05) 1.12 (7.89) 0.878 
Values are displayed as mean (SD) when normally distributed or median [interquartile range] (non-normally distributed). AF, atrial fibrillation; HT, 
hypertensive; VLF, very low frequency; LF, low frequency; HF, high frequency; MAP, mean arterial pressure; MCA Vmean, middle cerebral artery mean 
blood velocity. *p < 0.05 vs control. 
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Table 6.5. Dynamic cerebral autoregulation as quantified by transfer function analysis using signals of MAP and MCA Vmean during a repeated squat-to-
stand manoeuvre 
 
Control AF HT p value 
VLF (0.02–0.07 Hz) 
MAP power (mmHg2) 8.29 [5.88, 11.96] 5.90 [4.44, 10.33] 7.35 [3.40, 13.89] 0.704 
MCA Vmean power (cm
2·s-2) 4.50 [1.60, 7.00] 3.87 [1.76, 5.48] 2.54 [0.56, 4.16] 0.420 
Coherence 0.62 (0.14) 0.62 (0.15) 0.57 (0.09) 0.636 
Gain (cm·s-1·mmHg-1) 0.62 (0.23) 0.61 (0.18) 0.48 (0.19) 0.295 
Gain (%·mmHg-1) 0.98 (0.42) 1.09 (0.29) 1.00 (0.23) 0.698 
Phase (radians) 47.1 (16.5) 36.2 (12.4) 38.6 (7.8) 0.158 
LF (0.07–0.20 Hz) 
MAP power (mmHg2) 171.4 [131.1, 219.9] 179.3 [124.8, 301.3] 151.7 [107.0, 191.8] 0.844 
MCA Vmean power (cm
2·s-2) 110.8 (66.3) 118.0 (62.4) 74.1 (48.3) 0.300 
Coherence 0.83 [0.63, 0.89] 0.88 [0.81, 0.91] 0.77 [0.75, 0.88] 0.145 
Gain (cm·s-1·mmHg-1) 0.76 (0.20) 0.79 (0.25) 0.63 (0.28) 0.349 
Gain (%·mmHg-1) 1.02 [0.89, 1.39] 1.44 [1.12, 1.62] 1.25 [1.08, 1.38] 0.144 
Phase (radians) 20.2 (5.0) 17.6 (7.9) 16.4 (7.1) 0.535 
 
  
129 
 
 
 
Table 6.5 (continued). Dynamic cerebral autoregulation as quantified by transfer function analysis using signals of MAP and MCA Vmean during a 
repeated squat-to-stand manoeuvre 
 
Control AF HT p value 
HF (0.20–0.50 Hz) 
MAP power (mmHg2) 11.1 [7.1, 16.2] 10.4 [4.9, 26.4] 5.4 [4.1, 16.7] 0.512 
MCA Vmean power (cm
2·s-2) 8.11 (5.16) 7.63 (3.64) 3.20 (1.71)* 0.033 
Coherence 0.71 [0.52, 0.88] 0.82 [0.72, 0.89] 0.64 [0.45, 0.92] 0.220 
Gain (cm·s-1·mmHg-1) 0.70 (0.16) 0.74 (0.22) 0.58 (0.29) 0.283 
Gain (%·mmHg-1) 1.10 (0.31) 1.30 (0.27) 1.14 (0.32) 0.224 
Phase (radians) 2.65 (9.47) 4.08 (7.54) -0.25 (7.94) 0.534 
Values are displayed as mean (SD) when normally distributed or median [interquartile range] (non-normally distributed). AF, atrial fibrillation; HT, 
hypertensive; VLF, very low frequency; LF, low frequency; HF, high frequency; MAP, mean arterial pressure; MCA Vmean, middle cerebral artery mean 
blood velocity. *p < 0.05 vs control. 
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6.4. Discussion 
This study sought to determine whether cerebral vascular function is impaired in 
AF compared to healthy age-matched individuals as well as hypertensive 
(disease) controls. The major novel finding of this study is that AF patients had 
a lower hypercapnic CVRCO2 when compared to healthy age-matched controls, 
indicative of a lower cerebral vasodilatory reserve. In addition, it was observed 
that AF and hypertensive patients tended to have lower MCA Vmean than their 
healthy counterparts (non-significant), and that cerebral autoregulation via TFA 
showed a reduced coherence in very low and low frequency range in 
hypertensive, but not AF patients. The reduced cerebral vasodilatory reserve as 
characterized by the lower hypercapnic CVRCO2 noted in AF indicates that an 
impaired cerebral endothelial function or neural-glial NO synthesis may 
contribute to the increased stroke risk and poorer cerebral vascular disease 
outcomes in these patients. 
Resting cerebral perfusion 
Few studies have assessed cerebral perfusion in patients with AF. One study 
used the inhalation of [133Xe] to assess the cerebral blood flow in patients with 
AF in different age groups (Lavy et al., 1980). They reported a 17.5% lower 
cerebral perfusion in the AF group aged 35-50 years, 13.4% lower in the 51-65 
years group and a non-significant 5.5% reduction in the group >65 years when 
compared to age-matched healthy controls. Subgroup analysis revealed that 
the aetiology of AF (ischaemic heart disease, valvular AF or unknown origin) did 
not influence cerebral blood flow and it was suggested that cerebral perfusion 
would be reduced even with small changes in cardiac output. However, another 
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study assessed cerebral blood flow in patients undergoing electrical 
cardioversion and it was found that the cerebral perfusion was ≈12% higher 
after one day and ≈30% higher after 30 days of cardioversion with no significant 
changes in cardiac output (Petersen et al., 1989b). Similarly, during a bout of 
AF patients had a ≈12% reduction in MCA Vmean when compared to 
measurements after pharmacological cardioversion, but no significant 
differences were found in the basilar artery or ICA (Totaro et al., 1993). 
Furthermore, during acute stroke, individuals with AF have a lower MCA Vmean 
than people in sinus rhythm (Porebska et al., 2008), although the mechanisms 
underlying this reduction is still unknown. 
In accordance with previous studies, the results from this Chapter show that AF 
and hypertensive patients tended to have ≈17% lower baseline MCA Vmean with 
a moderate effect size, although this was not statistically significant. 
Furthermore, no significant differences were found in MAP or minute ventilation, 
but PETCO2 tended to be higher in hypertensive participants. A reduced cerebral 
perfusion particularly in the temporo-parieto-occipital region as assessed by 
SPECT has been found to correlate with lower scores in cognitive tests such as 
the mini mental state test (Thome et al., 1996). Therefore, the lower cerebral 
perfusion in AF patients may have important implications for the risk of 
complications such as cognitive decline and cerebral vascular disease, although 
the mechanism underpinning this reduction is still unknown. In addition, 
exercise training has been shown to be effective in improving quality of life in 
patients with AF (Osbak et al., 2011), and may be also used to improve cerebral 
haemodynamics in these patients. 
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CVRCO2 
This study was the first to assess the CVRCO2 in AF patients. CVRCO2 is the 
inherent ability of the cerebral vasculature to dilate in response to a hypercapnic 
stimulus or constrict in response to hypocapnia. It was found that AF patients 
had a lower hypercapnic but not hypocapnic CVRCO2 slope when compared to 
healthy or hypertensive control participants. CVRCO2 is reportedly impaired in 
conditions such as Alzheimer’s disease (Glodzik et al., 2013) and might 
increase the risk of complications in AF patients. One meta-analysis showed 
that an impaired CVRCO2 was associated with an increased risk of stroke 
(pooled random effects odds ratio: 3.86) in patients with internal carotid artery 
stenosis (Gupta et al., 2012). Furthermore, a study with 1695 participants and a 
follow-up time of 12 years revealed that there was an increase in hazard ratio 
for all-cause mortality of 1.1 per SD reduction in CVRCO2 (Portegies et al., 
2014). This association was even stronger when cardiovascular mortality was 
considered, with an increase in hazard ratio of 1.15 per SD decrease in 
CVRCO2. Interestingly, these associations were independent from stroke or 
cardiovascular risk factors, suggesting that impaired CVRCO2 may be associated 
with systemic vascular dysfunction. A low cerebral vasodilatory reserve may 
serve as an “early warning” as the cerebral vessels are not responding 
adequately to a physiological stressor. Future studies are needed to assess the 
impact of low CVRCO2 on the incidence of cerebral vascular events and mortality 
in patients with AF, as well as associations with a reduction in cerebral 
perfusion and cognition. 
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Although the mechanisms of cerebral vessels dilatation stimulated by CO2 are 
not fully known, it is accepted that extracellular pH, endothelial and smooth 
muscle potassium channels and NO are the major drivers of cerebral vascular 
tone (Kontos et al., 1977; Faraci & Brian, 1994; Faraci & Sobey, 1996; Kinoshita 
& Katusic, 1997). Under normocapnic conditions, infusion of a NO blocker in 
rats caused a ≈9 to 32% decrease in cerebral blood flow, while MAP increased 
by ≈10 to 52% (Wang et al., 1992). During a hypercapnic test, this effect was 
potentiated to a ≈32 to 52% reduction in cerebral blood flow when compared to 
control, indicating the importance of the NO pathway to the cerebral 
vasodilatory reserve. In humans, CVRCO2 has been shown to be impaired in 
patients with endothelial dysfunction (e.g. diabetes). Furthermore, 
administration of a NO donor such as sodium nitroprusside offsets this 
difference, indicating that the smooth muscle in these arteries appear to be 
intact (Lavi et al., 2006). Previous studies suggest that AF patients may have 
systemic endothelial dysfunction characterised by an increase in plasma von 
Willebrand factor, reduced nitrite/nitrate product and impaired flow-mediated 
dilatation of the brachial artery, which may contribute to the increase in risk of 
cerebral vascular disease (Conway et al., 2003; Freestone et al., 2008). 
Furthermore, in cultured human umbilical endothelial cells, laminar or pulsatile 
flow upregulates NO production while this is not seen in conditions of turbulent 
flow (Noris et al., 1995). This suggests that reduced shear stress may also play 
a role in the endothelium of AF patients due to the irregular heart rhythm. The 
data presented in this chapter is the first piece of evidence for a possible 
cerebral endothelial dysfunction in AF patients, possibily due to deranged NO 
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pathways. In addition, hypocapnic CVRCO2 was not significantly different 
between groups. This may be explained by the different mechanisms of 
regulation, since the NO pathway may be less active during hypocapnia (Wang 
et al., 1992). Alternatively, the lack of a difference between groups may be a 
due to a “floor effect” of the CVRCO2 curve, whereby hypocapnic changes in 
PaCO2 with the same magnitute of hypercapnic changes will generate a much 
smaller response in cerebral blood flow (Tominaga et al., 1976). 
Cerebral autoregulation 
Cerebral autoregulation is the ability of the cerebral blood vessels to adapt to 
changes in arterial blood pressure in order to protect the brain from hypo- and 
hyperperfusion (Aaslid et al., 1989). It has been shown to be impaired in a 
myriad of brain diseases such as traumatic brain injury (Czosnyka et al., 1997), 
cerebral vascular disease (Atkins et al., 2010) and Alzeimer’s disease (den 
Abeelen et al., 2014), as well as systemic diseases such as type 2 diabetes 
mellitus (Vianna et al., 2015). It has been proposed that AF patients have lower 
cerebral blood flow due to autoregulatory mechanisms (Lavy et al., 1980).  
However, it has also been proposed that a reduced cerebral blood flow could 
lead to cerebral vessels dilatation which may impair cerebral autoregulation 
(Aaslid et al., 1989). In addition, short periods of ventricular arrhythmia have 
been shown to promote a paradoxical contraction of the cerebral vessels in 
people with AF, but the effects of chronic supraventricular arrhythmia on the 
cerebral autoregulation remain to be elucidated (Grubb et al., 1997). However, 
in the present study no differences in TFA indices of cerebral autoregulation 
(gain or phase) were observed between AF patients and healthy controls. Thus, 
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this data suggests that cerebral autoregulation is preserved in AF patients, 
although a reduced TFA coherence at the very low and low frequencies was 
noted at baseline in hypertensive patients. Coherence has traditionally been 
used as an indication of the linearity between input (MAP) and output (MCA 
Vmean) and therefore the effectiveness of the transfer function (Zhang et al., 
2002; Ogoh et al., 2005). Many factors may cause low coherence values, 
including a nonlinear relationship between input and output, a poor signal-to-
noise ratio and the presence of other factors influencing the MCA Vmean. 
Furthermore, a low power MAP and MCA Vmean may also contribute to the low 
coherence in the baseline very low and low frequency ranges found in this 
Chapter (van Beek et al., 2008). Therefore, the results from baseline TFA could 
mean that there was a loss of linearity of the MCA Vmean responses to 
spontaneous fluctuations in MAP, with an increased influence of other factors 
and greater complexity of the responses in cerebral perfusion (Panerai et al., 
2006). However, the low coherence could also interfere with or even invalidate 
the interpretation of the TFA gain and phase, a reason that makes the use of 
manoeuvres to enhance coherence recommended (van Beek et al., 2008). A 
strength of the present study is that a repeated squat-to-stand manoeuvre was 
employed to substantially enhance MAP and MCA Vmean power, and thus 
coherence. However, no significant differences in gain, phase or coherence 
were observed between groups in the frequency ranges assessed. The concept 
that cerebral autoregulation is preserved in AF patients is further supported by 
the observation that the cerebrovascular responses to the single sit-to-stand 
were not different between groups. 
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The proposed mechanisms involved in the autoregulation process include 
stretch-activated cation channels (Davis et al., 1992), autonomic innervation 
(Hamner et al., 2010; Hamner et al., 2012) and even NO (White et al., 2000), 
although the latter is still debated (Zhang et al., 2004). As no differences in 
cerebral autoregulation were observed between groups, it is tempting to 
speculate that the underlying mechanisms are unaltered in AF patients, despite 
the CVRCO2 responses being blunted. Thus, it may be further speculated that 
the reduced cerebral vasodilatory reserve in AF patients might be as a result of 
endothelial but not smooth muscle dysfunction. This study paves the way for 
further mechanistic assessment of cerebral vascular function in this population. 
Cognition 
AF has been shown to be a risk factor for cognitive decline even without clinical 
history or radiologic signs of cerebral vascular disease (Ott et al., 1997; Knecht 
et al., 2008). Mild cognitive impairment is more likely to occur in AF patients 
with higher thromboembolic risk and lower education levels (Ball et al., 2013). 
One proposed mechanism for the cognitive decline is a reduced cerebral blood 
flow that leads to white matter damage (Raiha et al., 1993). However, other 
factors may influence such as the occurrence of cerebral microbleeds (Poels et 
al., 2012) and increased inflammatory markers (Kuo et al., 2005). No significant 
difference in cognition was found between the groups in this chapter. Some 
methodological considerations (explained below) must be taken under account 
when assessing the cognition findings from this chapter. 
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Limitations 
The use of changes in MCA Vmean measured by transcranial Doppler as a 
surrogate marker for cerebral blood flow is a subject of debate (Ainslie & 
Hoiland, 2014). There is contradictory evidence comparing this technique with 
absolute measures of cerebral blood flow (Bishop et al., 1986; Sorteberg et al., 
1989), as discussed in Chapter 5. Although it is well known that AF is a risk 
factor for cognitive decline and dementia, the cognition was not different 
between groups in this study. Several reasons may account to this, but the 
small sample size and a relatively low risk profile (normal blood cholesterol, 
absence of heart failure and no signs or history of cerebral vascular disease) in 
the population studied may be the main reasons. Post-hoc power analysis using 
the results found in this study showed that 17 participants per group would be 
needed to assess statistical significance of cognitive function.  
Perspective 
AF is strongly associated with age and is a risk factor for brain disease, 
although the mechanisms contributing to this increased risk are not fully 
understood. This study showed that AF patients had a lower hypercapnic 
CVRCO2 when compared to healthy controls. It can be speculated that cerebral 
endothelial dysfunction or neural-glial NO synthesis may be a significant 
contributor to the cerebral vascular risk in these patients, as vascular smooth 
muscle function seems to be preserved in AF patients. Future research is 
needed to provide evidence for the possible cerebral endothelial dysfunction 
and NO pathways in the brain of AF patients. This could be evaluated by the 
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administration of NO donors and blockers and comparing with other groups of 
patients with endothelial dysfunction and healthy individuals. Furthermore, 
further research is needed to elucidate whether cerebral and systemic 
vasomotor regulation are modified following exercise training in AF patients. 
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CHAPTER 7: GENERAL DISCUSSION AND FUTURE 
DIRECTIONS 
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The brain requires a high nutritive flow of oxygen and glucose, as well as 
removal of by-products resulting from cerebral metabolism. Short interruptions 
in the cerebral blood supply leads to symptoms such as seizures and fainting 
within a few seconds and, if not reversed immediately, may lead to permanent 
neurologic damage, dysfunction and death. On the other hand, excessive 
cerebral perfusion can cause cerebral vascular damage, increased intracranial 
pressure, stroke, and may also lead to neurologic damage, dysfunction and 
death. To prevent such situations from happening, the cerebral circulation 
counts on many different mechanisms of blood flow regulation, including 
adaptations to changes in metabolic activity, arterial blood gases, blood 
pressure, cardiac output and autonomic nervous system activity. Ageing is 
associated with a reduction in cerebral perfusion and is a well-known risk factor 
for cardiovascular disease, cognitive decline, dementia and cerebral vascular 
disease. Given this, therapeutic strategies to enhance brain health, such as 
exercise are warranted. This thesis aimed to determine the impact of physical 
activity and cardiorespiratory fitness on the cerebral blood flow and its 
regulation. Heart disease may further compromise cerebral vascular function, 
and it has also been associated with an increased risk of cerebral vascular 
disease, cognitive decline and dementia. The final aim of this thesis was to 
determine whether cerebral vascular function is impaired in sedentary old 
individuals and patients with AF, and thus represents a potential mechanism for 
the increased risk of brain disease in these populations. 
The study presented in chapter 4 aimed to determine if higher levels of 
objectively measured daily physical activity influence cerebral blood flow as 
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measured by duplex Doppler ultrasound and cognition in a cohort of healthy old 
individuals. It was found that: (i) cerebral blood flow was not different between 
groups despite a considerable difference (≈55%) in levels of daily physical 
activity; (ii) cognition was also not different between low and high physical 
activity groups. This was the first study to objectively measure daily physical 
activity using 7-day accelerometry while providing a volumetric assessment of 
cerebral blood flow using duplex Doppler ultrasound of the extracranial arteries 
in old individuals. Many previous studies showed that resting cerebral perfusion 
was associated with cardiorespiratory fitness (Ainslie et al., 2008; Bailey et al., 
2013b; Thomas et al., 2013). However, the fact that the study presented in 
chapter 4 did not show a difference in cerebral blood flow between low and high 
daily physical activity groups suggests that a higher degree of physical activity 
(e.g. exercise training) might be needed to evoke a chronically increased 
cerebral blood flow. Furthermore, this study was underpowered to assess 
cognition in this cohort of healthy older individuals and care must be taken when 
interpreting the results presented. 
Chapter 5 extended the findings of the previous chapter, with the aim of 
investigating if age and higher levels of cardiorespiratory fitness would influence 
cerebral blood flow at rest and during a hypercapnic challenge. This chapter 
also used duplex Doppler ultrasound of the extracranial vessels to determine 
cerebral blood flow and also assessed the blood flow responsiveness to 
increased levels of inspired CO2 at the ICA. It was found that: (i) bilateral ICA 
blood flow was ≈31% higher in trained individuals when compared to their 
untrained counterparts; (ii) bilateral VA flow was not influenced by either age or 
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cardiorespiratory fitness; (iii) MCA Vmean was lower in old individuals when 
compared to young, but was unaffected by cardiorespiratory fitness; (iv) there 
was a non-significant tendency for an enhanced ICA CVRCO2 in old trained 
individuals (d = 1.22), while MCA CVRCO2 did not appear to be influenced by 
age or training status. Many important interpretations can be made from these 
results. Firstly, the fact that a high cardiorespiratory fitness was associated with 
an increased bilateral ICA blood flow is in agreement with the current literature 
(Ainslie et al., 2008; Bailey et al., 2013b), however with the added benefit of 
showing an objective measurement of flow instead of surrogate markers. 
Secondly, the absence of a difference in bilateral VA flow between groups 
provides a more comprehensive assessment of global perfusion, as the anterior 
circulation appears to be favoured by the chronic adaptations of the cerebral 
circulation caused by exercise. It has been previously shown that responses to 
acute stressors such as head-up tilt and exercise at the ICA and VA are 
different (Sato et al., 2011; Sato et al., 2012a). However, this is the first time 
differential chronic adaptations to exercise were assessed in the ICA and VA. 
The fact that the bilateral ICA flow but not the MCA Vmean was influenced by 
cardiorespiratory fitness may relate to the number of participants in the study, 
making it underpowered for the expected MCA Vmean difference between 
groups. Finally, the tendency for an increased cerebrovascular dilatory reserve 
in old individuals with high cardiorespiratory fitness levels may be a mechanism 
contributing to the improved brain health in old people who exercise. 
The study presented in chapter 6 assessed the cerebral vascular function in 
patients with AF comparing with healthy controls or hypertensive individuals, 
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who served as a disease control. It was found that: (i) individuals with AF had 
lower CVRCO2 when compared to healthy controls; (ii) AF and hypertensive 
patients tended to have a reduced MCA Vmean when compared to healthy 
controls; (iii) cerebral autoregulation was preserved in AF patients, but a lower 
coherence in very low and low frequency range was observed in hypertensive 
patients. This study provides novel evidence for the impact of AF on the 
cerebral vascular regulation, which contributes to the understanding of the 
pathophysiology of the cerebral vascular disease in this patient population. The 
reduced cerebral vasodilatory reserve found in AF patients may contribute to 
the poorer prognosis to cerebral vascular events in this group when compared 
to people in sinus rhythm as shown previously (Lin et al., 1996). In fact, a lower 
CVRCO2 is associated with increased incidence of cerebral vascular events and 
mortality (Markus & Cullinane, 2001; Portegies et al., 2014). Potassium 
channels, NO and extracellular pH are proposed to be the major mechanisms 
underpinning the arterial dilatation promoted by CO2. An impaired systemic 
endothelial function has been found on AF patients (Conway et al., 2003; 
Freestone et al., 2008). Considering the CVRCO2 findings presented in chapter 
6, together with a preserved cerebral autoregulation and the systemic 
endothelial dysfunction presented in the background literature, it can be 
speculated that there is a dysfunction in the synthesis of NO at the brain 
vessels, which should be further investigated. 
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Future directions 
Many new questions arise from the studies performed for this thesis. Firstly, due 
to the cross-sectional design of the studies presented in this work some 
questions would require randomized controlled trials in order to be answered. 
One question that remains is: are the physical activity recommendations 
proposed by the current guidelines enough to improve cerebral structure, 
function and cognition? It would require a randomized controlled trial where old 
individuals who are sedentary (determined objectively using accelerometry) 
would be subject to a physical activity intervention, with measures of cognition, 
cerebral imaging and cerebral vascular function before and after the 
intervention. Furthermore, the results presented in the Chapters 4 and 5 are 
from healthy older individuals and may not be representative of the general 
population, as there is a high prevalence of chronic diseases in the older 
segments of the population. However, these Chapters aimed to assess the 
effects of physical activity, cardiorespiratory fitness and age per se on the 
cerebral vascular function. It was beyond the scope of this thesis to provide 
scientific evidence in a clinically diverse population. It is possible that people 
who have diseases that are associated with increased vascular risk (e.g. AF) 
may benefit more from the effects of exercise on the brain vessels, as it is 
shown in the peripheral circulation in diseases such as diabetes (Mikus et al., 
2011). Taking this under account, high physical activity or cardiorespiratory 
fitness may have greater impact on a more clinically diverse population, which 
would be representative of the general population. The effects of exercise 
training, physical activity or cardiorespiratory fitness on the cerebral circulation 
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may be more pronounced in a “less healthy” sample which would be more 
representative of the general population, but an approach closer to a pragmatic 
trial is necessary to assess the impact of exercise, physical activity or 
cardiorespiratory fitness on the cerebral blood flow and its regulation on the 
general population. However, the positive effects of high physical activity and 
exercise on the cognitive function and cardiovascular system warrants that 
exercise promotion should be a population-wide intervention including healthy 
individuals to improve quality of life and reduce the impact of disease in the 
ageing population (Bijnen et al., 1998; Garber et al., 2011; United Nations, 
2013). 
It is not known whether the cerebral vasodilatory reserve in AF patients would 
be improved with exercise training. Exercise training has been shown to be 
effective in improving exercise capacity and quality of life in AF patients (Osbak 
et al., 2011). In healthy old individuals, cardiorespiratory fitness seems to be 
associated with improved cerebral haemodynamics (Bailey et al., 2013b; 
Barnes et al., 2013; Braz et al., 2016), although it is not an universal finding 
(Thomas et al., 2013; Zhu et al., 2013). It is possible that individuals with an 
impaired CVRCO2 may benefit more from the exercise training than healthy 
individuals as exercise is known to improve endothelial function (Ross et al., 
2016), making this an attractive preventive and therapeutic intervention. Lastly, 
to confirm the role of NO on the impaired cerebral vasodilatory reserve in AF 
patients, CVRCO2 should be assessed at a baseline condition and after 
administration of a NO donor, such as glyceryl trinitrate, nitroprusside or L-
arginine. Animal studies may be required to assess if the dysfunction in NO 
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production has an endothelial, neuronal or glial origin with blockade of specific 
NO synthase enzymes. 
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